Podcasts about standardized

Is test prep a lifeline or a scam? Jessica Wynn reveals who's really cashing in on your SAT anxiety here on Skeptical Sunday!Welcome to Skeptical Sunday, a special edition of The Jordan Harbinger Show where Jordan and a guest break down a topic that you may have never thought about, open things up, and debunk common misconceptions. This time around, we're joined by writer and researcher Jessica Wynn!Full show notes and resources can be found here: jordanharbinger.com/1288On This Week's Skeptical Sunday:The test prep industry is a multi-billion-dollar machine built on manufactured anxiety — not better education. Companies exploit the fear that a single test determines your entire future, turning parental stress and student panic into a lucrative marketplace where confusion plus fear equals profit.The same corporations that create standardized tests often sell the prep materials to pass them — a staggering conflict of interest. It's vertical integration at its most cynical: they've engineered both the problem and the solution, and students pay on both ends.Standardized tests like the SAT don't predict college success as well as high school GPA does, and access to expensive prep widens inequality rather than leveling the playing field. Kids in the top 1% of income have a 1 in 4 shot at elite schools — kids in the bottom 20% have a 1 in 300 chance.Social media has supercharged test prep anxiety, turning studying into a performative competition. Students spiral comparing their materials and scores to strangers online, and prep companies profit without even advertising — the students do it for them through posts and affiliate links.You don't need to spend a fortune to prepare well. Start with official practice tests and free resources like Khan Academy, use proven techniques like spaced repetition and the Feynman method, and remember — one good resource used properly beats five expensive ones you never open.Connect with Jordan on Twitter, Instagram, and YouTube. If you have something you'd like us to tackle here on Skeptical Sunday, drop Jordan a line at jordan@jordanharbinger.com and let him know!Connect with Jessica Wynn at Instagram and Threads, and subscribe to her newsletters: Between the Lines and Where the Shadows Linger!And if you're still game to support us, please leave a review here — even one sentence helps! Sign up for Six-Minute Networking — our free networking and relationship development mini course — at jordanharbinger.com/course!Subscribe to our once-a-week Wee Bit Wiser newsletter today and start filling your Wednesdays with wisdom!Do you even Reddit, bro? Join us at r/JordanHarbinger!This Episode Is Brought To You By Our Fine Sponsors: HexClad: 10% off: hexclad.com/jordanBombas: Go to bombas.com/jordan to get 20% off your first orderWayfair: Start renovating: wayfair.comHomes.com: Find your home: homes.comThe President's Daily Brief: Listen here or wherever you find fine podcasts!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

To speak with an advisor and map out your student's next steps, book a Complimentary Strategy Call at admittedly.co/apply. In this episode of the Admittedly Podcast, Thomas sits down with Admittedly's Interim Director of College Counseling and former Senior Admissions Officer at Duke University, Sonam, for a candid look inside how highly selective admissions offices actually evaluate applications. Sonam reviewed more than 10,000 applications during her time in admissions. She holds degrees from Duke and an MBA from Rice, and she has worked across nearly every side of the process — inside a top university admissions office, in high schools, and in community-based organizations. In short: she understands both how decisions are made and how students should prepare. Together, Thomas and Sonam pull back the curtain on how admissions officers are trained, how institutional priorities shape decisions, and why the process is far more nuanced than most families realize. They discuss the return of standardized testing, what transcripts really signal, how committee rooms actually function, and why trying to "reverse engineer" a school's priorities is often a mistake. The conversation also dives deep into extracurricular strategy — what meaningful involvement looks like, how admissions officers spot inconsistencies, and why students don't need ten perfectly aligned activities to be compelling. From late bloomers to school list strategy to regional admissions nuances, this episode gives families a rare insider perspective grounded in real experience. This is especially valuable for parents and students aiming at highly selective colleges who want clarity about how decisions are made — and how to position themselves with intention rather than guesswork. Key Takeaways: • Admissions officers are trained — extensively — to evaluate applications within institutional priorities. • The supplemental essays often reveal more about what a school values than the personal statement. • Standardized testing is returning as a tool to combat grade inflation and assess academic readiness. • Admissions decisions are not pure meritocracies — they are shaped by institutional needs and shifting applicant pools. • Extracurriculars should demonstrate action and authenticity, not just alignment with a proposed major. • Changing direction mid-high school is acceptable — if it's explained thoughtfully and reflects genuine growth. • Students should build school lists based on fit, not assumptions about what a college "wants." Listeners can continue the conversation by following @admittedlyco on Instagram and TikTok, where Thomas and the Admittedly team answer real admissions questions weekly. Free resources, guides, and webinars are available at admittedly.co. If your family is ready for strategic, experience-driven guidance, book a Complimentary Strategy Call at admittedly.co/apply.  

Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first responders seeking psychedelic-assisted therapy retreats, often outside the United States. The conversation centers on veterans, the VA, and why that system may be the first realistic federal pathway for psychedelic care. Early Themes Lavasani describes PMC's work on Capitol Hill, including hosting events that bring lawmakers, staffers, and advocates into the same room. Her focus is steady engagement. In DC, progress often happens through repeated conversations, not headlines. Kopelman shares his background as a Marine and how his own psychedelic-assisted therapy experience led him to Mission Within. The foundation has funded more than 250 scholarships for veterans and first responders seeking treatment for PTSD, mild traumatic brain injury, depression, and addiction. They connect this work to pending veteran-focused legislation and explain why the VA matters. As a closed health system, the VA can pilot programs, gather data, and refine protocols without the pressures of private healthcare markets. Core Insights A recent Capitol Hill gathering, For Veteran Society, brought together members of Congress and leaders from the psychedelic caucus. Lavasani describes candid feedback from lawmakers. The message was clear: coordinate messaging, avoid fragmentation, and move while bipartisan interest remains. Veteran healthcare is not framed as the final goal. It is a starting point. If psychedelic therapies can demonstrate safety and effectiveness within the VA, broader adoption becomes more plausible. Kopelman raises operational realities that must be addressed: Standardized safety protocols across providers Integration support, not medication alone Clear training pathways for clinicians Real-world data beyond tightly screened clinical trials They also address recent negative headlines involving ibogaine treatment abroad. Kopelman emphasizes the need for shared learning across providers, especially when adverse events occur. Lavasani argues that inconsistency within the ecosystem can slow federal confidence. Later Discussion and Takeaways The discussion widens to federal momentum around addiction and mental health. Lavasani notes that new funding initiatives signal growing openness to innovative treatment models, even if psychedelics are not named explicitly in every announcement. Both guests stress that policy moves slowly by design. Meetings, follow-ups, and relationship building often matter more than public statements. For clinicians, researchers, operators, and advocates, the takeaways are direct: Veterans are likely the first federal pathway Public education remains essential Safety standards must be shared and transparent Integration and workforce development need attention now If psychedelic medicine enters federal systems, infrastructure will determine success. Frequently Asked Questions What do Melissa Lavasani & Jay Kopelman say about VA psychedelic policy? They argue that veteran-focused legislation offers a realistic first federal pathway for psychedelic-assisted care. Is ibogaine currently available through the VA? No. They discuss ibogaine in the context of private retreats and future possibilities, not an existing VA program. Why do Melissa Lavasani & Jay Kopelman emphasize coordination? Lawmakers respond more positively when advocates present aligned messaging and clear priorities. What safety issues are discussed by Melissa Lavasani & Jay Kopelman? They highlight the need for standardized screening, monitoring, integration support, and transparent review of adverse events. Closing Melissa Lavasani & Jay Kopelman provide a grounded look at how psychedelic policy develops inside federal systems. Their message is practical: veterans may be the first lane, but long-term success depends on coordination, safety standards, and sustained engagement. Closing This episode captures a real-time view of how federal policy could shape the next phase of the psychedelic resurgence, especially through veteran-facing legislation and VA infrastructure. Melissa Lavasani & Jay Kopelman argue that coordination, public education, and shared safety standards will shape whether access expands with credibility and care. Transcript Joe Moore: [00:00:00] Hello everybody. Welcome back to Psychedelics Today. Today we have two guests, um, got Melissa Sani from Psychedelic Medicine Coalition. We got Jake Pelman from Mission Within Foundation. We're gonna talk about I bga I became policy on a recent, uh, set of meetings in Washington, DC and, uh, all sorts of other things I'm sure. Joe Moore: But thank you both for joining me. Melissa Lavasani: Thanks for having us. Jay Kopelman: Yeah, it's a pleasure. Thanks. Joe Moore: Yeah. Um, Melissa, I wanna have you, uh, jump in. First. Can you tell us a little bit about, uh, your work and what you do at PMC? Melissa Lavasani: Yeah, so Psychedelic Medicine Coalition is, um, the only DC based Washington DC based advocacy organization dedicated to the advancing the issue of psychedelics, um, and making sure the federal government has the education they need, um, and understands the issue inside out so that they can generate good policy around, around psychedelic medicines. Melissa Lavasani: [00:01:00] Uh, we. Host Hill events. We host other convenings. Our big event every year is the Federal Summit on psychedelic medicine. Um, that's going to be May 14th this year. Um, where we talk about kinda the pressing issues that need to be talked about, uh, with government officials in the room, um, so that we can incrementally move this forward. Melissa Lavasani: Um, our presence here in Washington DC is, is really critical for this issue's success because, um, when we're talking about psychedelic medicines, um, from the federal government pers perspective, you know, they are, they are the ones that are going to initiate the policies that create a healthcare system that can properly facilitate these medicines and make sure, um, patient safety is a priority. Melissa Lavasani: And there's guardrails on this. And, um, you know, there, it's, it's really important that we have. A home base for this issue in Washington DC just [00:02:00] because, uh, this is very complicated as a lot of your viewers probably understand, and, you know, this can get lost in the mix of all the other issues that, um, lawmakers in DC are focused on right now. Melissa Lavasani: And we need to keep that consistent presence here so that this continues to be a priority for members of Congress. Joe Moore: Mm. I love this. And Jay, can you tell us a bit about yourself and mission within Foundation? Jay Kopelman: Yeah, sure. Joe, thanks. Uh, I, I am the CEO of Mission within Foundation. Prior to this, most of my adult life was spent in the military as a Marine. Jay Kopelman: And I came to this. Role after having, uh, a psychedelic assisted therapy experience myself at the mission within down in Mexico, which is where pretty much we all go. Um, we are here to help [00:03:00] provide, uh, access for veterans and first responders to be able to attend psychedelic assisted therapy retreats to treat issues like mild TBI, post-traumatic stress disorder, uh, depression, sometimes addiction at, at a very low level. Jay Kopelman: Um, and, and so we've, we've been doing this for a little more than a year now and have provided 250 plus scholarships to veterans and first responders to be able to access. These retreats and these, these lifesaving medicines. Um, we're also partnered, uh, you may or may not know with Melissa at Psychedelic Medicine Coalition to help advance education and policy, specifically the innovative, uh, therapy Centers of Excellence Act [00:04:00] that Melissa has worked for a number of years on now to bring to both Houses of Congress. Joe Moore: Thank you for that. Um, so let's chat a little bit about what this event was that just, uh, went down, uh, what, what was it two weeks ago at this point? Melissa Lavasani: Yeah. Yeah. It's called For Veteran Society and it's all, um, there's a lot of dialogue on Capitol Hill about veterans healthcare and psychedelics, but where I've been frustrated is that, you know, it was just a lot of. Melissa Lavasani: Talk about what the problems are and not a lot of talk about like how we actually propel things forward. Um, so it, at that event, I thought it was really important and we had three members of Congress there, um, Morgan Latrell, who has been a champion from day one and his time in Congress, um, having gone through the experience himself, um, [00:05:00] at Mission within, um, and then the two chairs of the psychedelic caucus, uh, Lou Correa and Jack Bergman. Melissa Lavasani: And we really got down to the nitty gritty of like w like why this has taken so long and you know, what is actually happening right now? What are the possibilities and what the roadblocks are. And it was, I thought it was a great conversation. Um, we had an interesting kind of dynamic with Latres is like a very passionate about this issue in particular. Melissa Lavasani: Um, I think it was, I think it was really. A great event. And, you know, two days later, Jack Bergman introduced his new bill for the va. Um, so it was kind of like the precursor to that bill getting introduced. And we're just excited for more and more conversations about how the government can gently guide this issue to success. Joe Moore: Hmm. Yeah. [00:06:00] That's fantastic. Um, yeah, I was a little bummed I couldn't make it, but next time, I hope. But I've heard a lot of good things and, um, it's, it sounded like there was some really important messages in, in terms of like feedback from legislators. Yeah. Yeah. Could you speak to that? Melissa Lavasani: Yeah, I mean, I think when, uh, representative Latrell was speaking, he really impressed on us a couple things. Melissa Lavasani: Um, first is that, you know, they really kind of need the advocates to. Coordinate, collaborate and come up with like a, a strategic plan, you know, without public education. Um, talking to members of Congress about this issue is, is really difficult. You know, like PMC is just one organization. We're very little mission within, very little, um, you know, we're all like, kind of new in navigating, um, this not so new issue, but new to Washington DC [00:07:00] issue. Melissa Lavasani: Um, without that public education as a baseline, uh, it's, it's, you have to spend a lot of time educating members of Congress. You know, that's like one of our things is, you know, we have to, we don't wanna tell Congress what direction to go to. We wanna provide them the information so they understand it very intimately and know how to navigate through things. Melissa Lavasani: Um, and secondly. Um, he got pretty frank with us and said, you know, we've got one cha one chance at this issue. And it's like, that's, that's kind of been like my talking point since I started. PMC is like, you have a very limited window, um, when these kind of issues pop up and they're new and they're fresh and you have a lot of the veteran community coming out and talking about it. Melissa Lavasani: And there's a lot of energy there. But now is the time to really move forward, um, with some real legislation that can be impactful. Um, but, you know, we've gotta [00:08:00] be careful. We, we forget, I think sometimes those of us who are in the ecosystem forget that our level of knowledge about these medicines and a lot of us have firsthand experience, um, with these drugs and, and our own healing journeys is, um, we forget that there is a public out there that doesn't have the level of knowledge that we all have. Melissa Lavasani: And, um. We gotta make sure that we're sticking to the right elements of, of, of what needs to happen. We need to be sure that our talking points are on track and we're not getting sideways about anything and going down roads that we don't need to talk about. It's why, um, you know, PMC is very focused on, um, moving forward veteran legislation right now. Melissa Lavasani: Not because we're a veteran organization, but because we're, we see this long-term policy track here. Um, we know where we want to get [00:09:00] to, um. Um, and watching other healthcare issues kind of come up and then go through the VA healthcare system, I think it's a really unique opportunity, um, to utilize the VA as this closed system, the biggest healthcare system in the country to evaluate, uh, how psychedelics operate within systems like that. Melissa Lavasani: And, you know, before they get into, um, other healthcare systems. What do we need to fix? What do we need to pay attention to? What's something that we're paying too much attention to that doesn't necessarily need that much attention? So it's, um, it's a real opportunity to look at psychedelic medicines within a healthcare system and obviously continue to gather the data. Melissa Lavasani: Um, Bergman's Bill emerging, uh, expanding veteran access to emerging treatments. Um, not only mandates the research, it gives the VA authority for this, uh, for running trials and, and creating programs around psychedelic medicines. But also, [00:10:00] one of the great things about it, I think, is it provides an on-ramp for veterans that don't necessarily qualify for clinical trials. Melissa Lavasani: You know, I think that's one of the biggest criticisms of clinical trials is like you're cre you're creating a vacuum for people and people don't live in a vacuum. So we don't necessarily know what psychedelics are gonna look like in real life. Um, but with this expanding veteran access bill that Bergman introduced, it provides the VA an opportunity to provide this access under. Melissa Lavasani: Um, in a, in a safe container with medical supervision while collecting data, um, while ensuring that the veteran that is going through this process has the support systems that it needs. So, um, you know, I think that there's a really unique opportunity here, and like Latrell said, like, we've got one shot at this. Melissa Lavasani: We have people's attention in Congress. Um, now's the time to start acting, and let's be really considerate and thoughtful about what we're doing with it. Joe Moore: Thanks for that, Melissa and Jay, how, [00:11:00] anything to add there on kind of your takeaways from the this, uh, last visit in dc? Jay Kopelman: Yeah, I, I think that Melissa highlighted it really well and there, there were a couple other things that I, I think, you know, you could kind of tie it all together with some other issues that we face in this country, uh, and that. Jay Kopelman: Uh, representative Correa brought up as well, but one of the things I wanted to go back and say is that veterans have kind of led this movement already, right? So, so it's a, it's a good jumping off point, right? That it's something people from both sides of the aisle, from any community in America can get behind. Jay Kopelman: You know, if you think about it, uh, in World War ii, you know, we had a million people serving our population was like, not even 200 million, but now [00:12:00] we have a population of 330 million, and at any given time there might be a million people in uniform, including the Reserve and the National Guard. So it's, it, it's an easy thing to get behind this small part of the population that is willing to sign that contract. Jay Kopelman: Where you are saying, yeah, I'm going to defend my country, possibly at the risk of my l my own life. So that's the first thing. The other thing is that the VA being a closed health system, and they don't have shareholders to answer to, they can take some risks, they can be innovative and be forward thinking in the ways that some other healthcare systems can't. Jay Kopelman: And so they have a perfect opportunity to show that they truly care for their veterans, which don't, I'm not saying they don't, but this would be an [00:13:00] opportunity to show that carrot at a whole different level. Uh, it would allow them to innovate and be a leader in something as, uh, as our friend Jim Hancock will say, you know. Jay Kopelman: When he went to the Naval Academy, they had the world's best shipbuilding program. Why doesn't the VA have the world's best care program for things like TBI and PTSD, which affects, you know, 40 something percent of all veterans, right? So, so there's, there's an opportunity here for the VA to lead from the front. Jay Kopelman: Um, the, these medicines provide, you know, reasonably lasting care where it's kind of a one and done. Whereas with the current systems, the, you know, and, and [00:14:00] again, not to denigrate the VA in any way, they're doing the best job they can with the tools in their toolbox, right? But maybe it's time for a trip to Home Depot. Jay Kopelman: Let's get some new tools. And have some new ways of fixing what's broken, which is really the way of doing things. It's not, veterans aren't broken, we are who we are. Um, but it's a, it's a way to fix what isn't working. So I, I think that, you know, given there's tremendous veteran homelessness still, you know, addiction issues, all these things that do translate to the population at large are things that can be worked on in this one system, the va that can then be shown to have efficacy, have good data, have [00:15:00] good outcomes, and, and take it to the population at large. Joe Moore: Mm-hmm. Brilliant. Thanks for that. And so there was another thing I wanted to pivot to, which is some of the recent press. So we've, um, seen a little bit of press around some, um, in one instance, some bad behavior in Mexico that a FI put out Americans thrive again, put out. And then another case there was a, a recent fatality. Joe Moore: And I think, um, both are tragic. Like we shouldn't be having to deal with this at this point. Um, but there's a lot of things that got us here. Um, it's not necessarily the operator's fault entirely, um, or even at all, honestly, like some medical interventions just carry a lot of risk. Like think, think about like, uh, how risky bypass surgery was in the nineties, right? Joe Moore: Like people were dying a lot from medical interventions and um, you know, this is a major intervention, uh, ibogaine [00:16:00] and also a lot of promise. To help people quite a bit. Um, but as of right now, there's, there's risk. And part of that risk, in my opinion, comes from the inability of organizations to necessarily collaborate. Joe Moore: Like there's no kind of convening body, sitting in the middle, allowing, um, for, and facilitating really good data sharing and learnings. Um, and I don't, I don't necessarily see an organization stepping up and being the, um, the convener for that kind of work. I've heard rumors that something's gonna happen there, and I'm, I'm hopeful I'll always wanna share my opinion on that. Joe Moore: But yeah. I don't know. Jay, from your perspective, is there anything you want to kind of speak to about, uh, these two recent incidents that Americans for Iboga kind of publicized recently? Jay Kopelman: Yeah, so I, I'll echo your sentiment, of course, that these are tragic incidents. Um, and I, [00:17:00] I think that at least in the case of the death at Ambio, AMBIO has done a very good job of talking about it, right? Jay Kopelman: They've been very honest with the information that they have. And like you said, there are risks inherent to these medicines, and it's like anything else in medicine, there are going to be risks. You know, when I went through, uh, when I, when I went through chemo, you know, there were, there are risks. You know, you don't feel well, you get sick. Jay Kopelman: Um, and, and it. There are processes in place to counter that when it happens. And there are processes and, and procedures and safety protocols in place when caring for somebody going through an ibogaine [00:18:00] journey. Uh, when I did it, we had EKG echocardiogram. You're on a heart monitor the entire time they push magnesium via iv. Jay Kopelman: You have to provide a urinalysis sample to make sure that there is nothing in your system that is going to potentially harm you. During the ibogaine, they have, uh, a cardiologist who is monitoring the heart monitors throughout the ibogaine experience. So the, the safety protocols are there. I think it's, I think it's just a matter of. Jay Kopelman: Standardizing them across all, all providers, right? Like, that would be a good thing if people would talk to one another. Um, as, as in any system, right? You've gotta have [00:19:00] some collaboration. You've gotta have standardization, you know, so, you know, they're not called standard operating procedures for nothing. Jay Kopelman: That means that in a, you know, in a given environment, everybody does things the same way. It's true in Navy and Marine Corps, air Force, army Aviation, they have standard operating procedures for every single aircraft. So if you fly, let's say the F 35 now, right? Because it's flown by the Navy, the Marine Corps, and the Air Force. Jay Kopelman: The, the emergency procedures in that airplane are standardized across all three services, so you should have the same, or, you know, with within a couple of different words, the same procedures and processes [00:20:00] across all the providers, right? Like maybe in one document you're gonna change, happy to glad and small dog to puppy, but it's still pretty much the, the same thing. Jay Kopelman: And as a service that provides scholarships to people to go access these medicines and go to these retreats, you know, my criteria is that the, this provider has to be safe. Number one, safety's paramount. It's always gotta be very safe. It should, it has to be effective. And you know, once you have those two things in place, then I have a comfort level saying, okay, yeah, we'll work with this provider. Jay Kopelman: But until those standardized processes are in place, you'll probably see these one-off things. I mean, some providers have been doing this longer than others and have [00:21:00] really figured out, you know, they've, they've cracked the code and, you know, sharing that across the spectrum would be good. Um, but just when these things happen, having a clearing house, right, where everybody can come together and talk about it, you know, like once the facts are known because. Jay Kopelman: To my knowledge, we still don't know all the facts. Like as, you know, as horrible as this is, you still have to talk about like an, has an autopsy been performed? What was found in the patient's system? You know, there, there are things there that we don't know. So we need to, we need to know that before we can start saying, okay, well this is how we can fix that, because we just don't know. Jay Kopelman: And, you know, to their credit, you know, Amio has always been safe to, to the, to the best of my knowledge. You know, I, [00:22:00] I haven't been to Ambio myself, but people that I have worked with have been there. They have observed, they have seen the process. They believe it's safe, and I trust their opinion because they've seen it elsewhere as well. Jay Kopelman: So yeah, having, having that one place where we can all come together when this happens, it, it's almost like it should be mandatory. In the military when there's a training accident, we, you know, we would have to have what's called a safety standout. And you don't do that again for a little while until you figure out, okay, how are we going to mitigate that happening again? Jay Kopelman: Believe me, you can go overboard and we don't want to do that. Like, we don't wanna just stop all care, but maybe stop detox for a week and then come back to it. [00:23:00] Joe Moore: Yeah. A dream would be, let's get like the, I don't know, 10, 20 most popular, uh, or well-known operators together somewhere and just do like a three day debrief. Joe Moore: Hey, everybody, like, here's what we see. Let's work on this together. You know how normal medicine works. And this is, it's hard because this is not necessarily, um, something people feel safe about in America talking about 'cause it's illicit here. Um, I don't understand necessarily how the operations, uh, relate to each other in Mexico, but I think that's something to like the public should dig into. Joe Moore: Like, what, what is this? And I, I'll start digging into that. Um, I, I asked a question recently of somebody like, is there some sort of like back channel signal everybody's using and there's no clear Yes. You know? Um, I think it would be good. That's just a [00:24:00] start, you know, that's like, okay, we can actually kind of say hi and watch out for this to each other. Jay Kopelman: It's not like we don't all know one another, right? Joe Moore: Yes. Jay Kopelman: Like at least three operators we're represented. At the Aspen Ibogaine meeting. So like that could be, and I think there was a panel kind of loosely related to this during Aspen Ibogaine meeting, but Joe Moore: mm-hmm. Jay Kopelman: It, you know, have a breakout where the operators can go sit down and kind of compare notes. Joe Moore: Right. Yeah. Melissa, do you have any, uh, comments on this thread here? And I, I put you on mute if you didn't see that. Um, Melissa Lavasani: all right, I'm off mute. Um, yeah, I think that Jay's hits the nail on the head with the collaboration thing. Um, I think that it's just a [00:25:00] problem across the entire ecosystem, and I think that's just a product of us being relatively new and upcoming field. Melissa Lavasani: Um, uh, it's a product of, you know. Our fundraising community is really small, so organizations feel like they are competing for the same dollars, even though their, their goals are all the same, they have different functions. Um, I think with time, I mean, let's be honest, like if we don't start collaborating and, and the federal government's moving forward, the federal government's gonna coordinate for us. Melissa Lavasani: And not, that might not necessarily be a bad thing, but, you know, we understand this issue to a whole other level that the federal government doesn't, and they're not required to understand it deeply. They just need to know how to really move forward with it the proper way. Um, but I think that it. It's really essential [00:26:00] that we all have this come together moment here so we can avoid things. Melissa Lavasani: Uh, I mean, no one's gonna die from bad advocacy. So like I've, I have a bit of an easier job. Um, but it can a, a absolutely stall efforts, um, to move things forward in Washington DC when, um, one group is saying one thing, another group is saying another thing, like, we're not quite at a point yet where we can have multiple lines of conversation and multiple things moving forward. Melissa Lavasani: Um, you know, for PMC, it's like, just let's get the first thing across the finish line. And we think that is, um, veteran healthcare. And, um, I know there's plenty of other groups out there that, that want the same thing. So, you know, I always, the reason why I put on the Federal Summit last year was I kind of hit my breaking point with a lack of collaboration and I wanted to just bring everyone in the same room and say like, all right, here are the things that we need to talk about. Melissa Lavasani: And I think the goal for this year is, um. To bring people in the same room and say, we talked about [00:27:00] we scratched the surface last year and this is where we need to really put our efforts into. And this is where the opportunities are. Um, I think that is going to, that's going to show the federal government if we can organize ourselves, that they need to take this issue really seriously. Melissa Lavasani: Um, I don't think we've done a great job at that thus far, but I think there's still plenty of time for us to get it together. Um, and I'm hoping with these two, uh, VA bills that are in the house right now and Senate is, is putting together their version of these two bills, um, so that they can move in tandem with each other. Melissa Lavasani: I think that, you know, there's an opportunity here for. Us to show the federal government as an ecosystem, Hey, we, we are so much further ahead and you know, this is what we've organized and here's how we can help you, um, that would make them buy into this issue a bit more and potentially move things forward faster. Melissa Lavasani: Uh, at this point in time, it's, I think that, [00:28:00] you know, psychedelics aren't necessarily the taboo thing that they, they used to be, but there's certainly places that need attention. Um, there's certainly conversations that need to be had, and like I said, like PMC is just one organization that can do this. Um, we can certainly organize and drive forward collaboration, but I, like we alone, cannot cover all this ground and we need the subject matter experts to collaborate with us so we can, you know, once we get in the door, we wanna bring the experts in to talk to these officials about it. Melissa Lavasani: So I. I, I really want listeners to really think about us as a convener of sorts when it comes to federal policy. Um, and you know, I think when, like for example, in the early eighties, a lot of people have made comparisons to the issue of psychedelics to the issue of AIDS research and how you have in a subject matter that's like extremely taboo and a patient population that the government [00:29:00] quite honestly didn't really care about in the early eighties. Melissa Lavasani: But what they did as an ecosystem is really organized themselves, get very clear on what they wanted the federal government to do. And within a matter of a couple years, uh, AIDS research funding was a thing that was happening. And what that, what that did was that ripple effect turned that into basically finding new therapies for something that we thought was a death, death sentence before. Melissa Lavasani: So I think. We just need to look at things in the past that have been really successful, um, and, and try to take the lessons from all of these issues and, and move forward with psychedelics. Joe Moore: Love that. And yes, we always need to be figuring out efficient approaches and where it has been successful in the past is often, um, an opportunity to mimic and, and potentially improve on that. Melissa Lavasani: Yeah. Jay Kopelman: One, one thing I think it's important to add to this part of the conversation is that, [00:30:00] you know, Melissa pointed out there are a number of organizations that are essentially doing the same thing. Jay Kopelman: Um, you know, I like to think we do things a little bit differently at Mission within Foundation in that we don't target any one specific type of service member. We, we work with all veterans. We work with first responders, but. What that leads to is that there are, as far as I've seen, nothing but good intentioned people in this space. Jay Kopelman: You know, people who really care about their patient population, they care about healing, they are trying to do a good job, and more importantly, they're trying to do good. Right? It, it, I think they all see the benefit down the road that this has, [00:31:00] pardon me, not just for veterans, but for society as a whole. Jay Kopelman: And, and ultimately that's where I would like to see this go. You know, I, I would love to see the VA take this. Take up this mantle and, and run with it and provide great data, great outcomes. You know, we are doing some data collection ourselves at Mission within foundation, albeit anecdotal based on surveys given before and after retreats. Jay Kopelman: But we're also working with, uh, Greg Fonzo down at UT Austin on a brain study he's doing that will have 40 patients in it when it's all said and done. And I think we have two more guys to put through that. Uh, and then we'll hit the 40. So there, there's a lot of good here that's being done by some really, really good people who've been doing this for a long time [00:32:00] and want to want nothing more than to, to see this. Jay Kopelman: Come to, come full circle so that we can take care of many, many, many people. Um, you know, like I say, I, I wanna work myself out of a job here. I, I just, I would love to see this happen and then I, you know, I don't have to send guys to Mexico to do this. They can go to their local VA and get the care that they need. Jay Kopelman: Um, but one thing that I don't think we've touched on yet, or regarding that is that the VA isn't designed for that. So it's gonna be a pretty big lift to get the right types of providers into the va with the knowledge, right, with the institutional knowledge of how this should be done, what is safe, what is effective, um, and then it, it's not just providing these medicines to [00:33:00] people and sending them home. Jay Kopelman: You don't just do that, you've gotta have the right therapists on the backend who can provide the integration coaching to the folks who are receiving these medicines. And I'm not just talking, I bga, even with MDMA and psilocybin, you should have a proper period of integration. It helps you to understand how this is going to affect you, what it, what the experience really meant, you know, because it's very difficult sometimes to just interpret it on your own. Jay Kopelman: And so what the experience was and what it meant to you. And, and so it will take some time to spin all that up. But once it's, once it's in place, you know, the sky's the limit. I think. Joe Moore: Kinda curious Jay, about what's, what's going on with Ibogaine at the federal level. Is there anything at VA right now? [00:34:00] Jay Kopelman: At the va? No, not with ibogaine. And, you know, uh, we, we send people specifically for IBOGAINE and five MEO, right? And, and so that, that doesn't preclude my interest in seeing this legislation passed, right? Jay Kopelman: Because it, it will start with something like MDMA or psilocybin, but ultimately it could grow to iboga, right? It the think about the cost savings at, at the va, even with psilocybin, right? Where you could potentially treat somebody with a very inexpensive dose of psilocybin or, or iboga one time, and then you, you don't have to treat them again. Jay Kopelman: Now, if I were, uh, you know, a VA therapist who's not trained in psychedelic trauma therapy. I might be worried [00:35:00] about job security, but it's like with anything, right? Like ultimately it will open pathways for new people to get that training or the existing people to get that training and, and stay on and do that work. Jay Kopelman: Um, which only adds another arrow to their quiver as far as I'm concerned, because this is coming and we're gonna need the people. It's just like ai, right? Like ai, yeah. Some people are gonna lose some jobs initially, and that's unfortunate. But productivity ultimately across all industries will increase and new jobs will be created as a result of that. Jay Kopelman: I mean, I was watching Squawk Box one morning. They were talking about the AI revolution and how there's gonna be a need for 500,000 electricians to. Build these systems that are going to work with the AI [00:36:00] supercomputers and, and so, Joe Moore: mm-hmm. Jay Kopelman: Where, where an opportunity may be lost. I think several more can be gained going forward. Melissa Lavasani: And just to add on what Jay just said there, there's nothing specific going on with Ibogaine at, at the va, but I think this administration is, is taking a real look at addiction in particular. Uh, they just launched, uh, a new initiative, uh, that's really centered on addiction treatments called the Great American Recovery. Melissa Lavasani: And, um, they're dedicating a hundred million dollars towards treating addiction as like a chronic treatable disease and not necessarily a law enforcement issue. So, um, in that initiative there will be federal grant programs for prevention and treatment and recovery. And, um, while this isn't just for psychedelic medicines, uh, I think it's a really great opportunity for the discussion of psychedelics to get elevated to the White House. Melissa Lavasani: Um, [00:37:00] there's also, previous to this announcement last week from the White House, there's been a hundred million dollars that was dedicated at, um, at ARPA h, which is. The advanced research projects, uh, agency for healthcare, um, and that is kind of an agency that's really focused on forward looking, um, treatments and technologies, uh, for, um, a, a whole slew of. Melissa Lavasani: Of issues, but this a hundred million dollars is dedicated to mental health and addiction. So there's a lot of opportunity there as well. So we, while I think, you know, some people are talking about, oh, we need a executive order on Iboga, it's like, well, you know, the, the president is thinking, um, about, you know, what issues can land with his, uh, voting block. Melissa Lavasani: And I think it's, I don't think we necessarily need a specific executive order on Iboga to call this a success. It's like, let's look at what, [00:38:00] um, what's just been announced from the White House. They're, they're all in on. Thinking creatively and finding, uh, new solutions for this. And this is kind of, this aligns with, um, HHS secretaries, uh, Robert F. Melissa Lavasani: Kennedy Junior's goals when he took on this, this role of Health Secretary. Um, addiction has been a discussion that, you know, he has personal, um, a personal tie to from his own experience. And, um, I think when this administration started, there was so much like fervor around the, the dialogue of like, everyone's talking about psychedelics. Melissa Lavasani: It was Secretary Kennedy, it was, uh, secretary Collins at the va. It was FDA Commissioner Marty Macari. And I think that there's like a lot of undue frustration within folks 'cause um, you don't necessarily snap your fingers and change happens in Washington dc This is not the city for that. And it's intentionally designed to move slow so that we can avoid really big mistakes. Melissa Lavasani: Um. [00:39:00] I think we're a year into this administration and these two announcements are, are pretty huge considering, um, you know, the, we, there are known people within domestic policy council that don't, aren't necessarily supportive of psychedelic medicine. So there's a really amazing progress here, and frustrating as it might be to, um, just be waiting for this administration to make some major move. Melissa Lavasani: I think they are making major moves like for Washington, DC These, these are major moves and we just gotta figure out how we can, um, take these initiatives and apply them to the issue of psychedelic medicines. Joe Moore: Thanks, Melissa. Um, yeah, it is, it is interesting like the amount of fervor there was at the beginning. You know, we had, uh. Kind of one of my old lawyers, Matt Zorn, jumped in with the administration. Right. And, um, you know, it was, uh, really cool to [00:40:00] see and hopeful how much energy was going on. It's been a little quiet, kind of feels like a black box a little bit, but I, you know, there was, Melissa Lavasani: that's on me. Melissa Lavasani: Maybe I, we need to be more out in public about like, what's actually happening, because I feel like, like day in and day out, it's just been, you gotta just mm-hmm. Like have that constant beat with the government. Mm-hmm. And, um, it's, it's, it's not the photo ops on the hill, it's the conversations that you have. Melissa Lavasani: It's the dinner parties you go to, it's the fundraisers you attend, you know? Mm-hmm. That's why I, I kind of have to like toot my own horn with PCs. Like, we need to be present here at, at not only on the Hill, not only at the White House, but kind of in the ecosystem of Washington DC itself. There's, it's, there are like power players here. Melissa Lavasani: There are people that are connected that can get things done, like. I mean, the other last week we had a big snow storm. I walked over to my friend's house, um, to have like a little fire sesh with them and our kids, and his next door neighbor came over. He was a member of Congress. I talked about the VA bills, like [00:41:00] we're reaching out to his office now, um, to get them, um, up to speed and hopefully get their co-sponsorship for, uh, the two VA bills. Melissa Lavasani: So, I mean, it, the little conversations you have here are just as important as the big ones with the photo ops. So, um, it, it's, it's really like, you know, building up that momentum and, and finding that time where you can really strike and make something happen. Joe Moore: Mm-hmm. Yeah. Jay, anything to add there? Jay Kopelman: Yeah, I was just gonna say that, you know, I, I, I think the fervor is still there, right? Jay Kopelman: But real life happens. Melissa Lavasani: Yes, Jay Kopelman: yes. And gets in the way, right? So, Melissa Lavasani: yeah, Jay Kopelman: I, I can't imagine how many issues. Secretary Kennedy has every day much less the president. Like there's so many things that they are dealing with on a daily basis, right? It, we, we just have to work to be the squeaky wheel in, in the right way, right. Jay Kopelman: [00:42:00] With the, with the right information at the right time. Like just inundating one of these organizations with noise, it's then it be with Informa, it just becomes noise, right? It it, it doesn't help. So when we have things to say that are meaningful and impactful, we do, and Melissa does an amazing job of that. Jay Kopelman: But, you know, it, it takes time. You know, it's, you know, we're not, this is, this is like turning an aircraft carrier, not a ski boat. Melissa Lavasani: Yeah, Joe Moore: yeah, absolutely. Um, and. It's, it's understandably frustrating, I think for the public and the psychedelic public in particular because we see all this hope, you know, we continue to get frustrated at politics. It's nothing new, right? Um, and we, we wanna see more people get well immediately. [00:43:00] And I, I kind of, Jay from the veteran perspective, I do love the kind of loud voices like, you're making me go to Mexico for this. Joe Moore: I did that and you're making me leave the country for the thing that's gonna fix me. Like, no way. And barely a recognition that this is a valid treatment. You know, like, you know, that is complicated given how medicine is structured here domestically. But it's also, let's face the facts, like the drug war kind of prevented us from being able to do this research in the first place. Joe Moore: You know? Thanks Nixon. And like, how do we actually kind of correct course and say like, we need to spend appropriately on science here so we can heal our own people, including veterans and everybody really. It's a, it's a dire situation out there. Jay Kopelman: Yeah. It, it really is. Um, you know, we were talking briefly about addicts, right? Jay Kopelman: And you know, it's not sexy. People think of addicts as people who are weak-minded, [00:44:00] right? They don't have any self-control. Um, but, but look at, look at the opioid crisis, right? That Brian Hubbard was fighting against in Kentucky for all those years. That that was something that was given to the patient by a doctor that they then became dependent on, and a lot of people died from that. Jay Kopelman: And, and so you, you know, it's, I I don't think it's fair to just put all addicts in a box. Just like it's not fair to put all veterans in a box. Just like it's not fair for doctors, put all their patients in a box. We're individuals. We, we have individual needs. Our, our health is very individual. Like, I, I don't think I should be put in the same box as every other 66-year-old that my doctor sees. Jay Kopelman: It's not fair. [00:45:00] You know, if you, if you took my high school classmates and put us all in a photo, we're all gonna have different needs, right? Like, some look like they're 76, not 66. Some look like they're 56. Not like they're, we, we do things differently. We live our lives differently. And the same is true of addicts. Jay Kopelman: They come to addiction from different places. Not everybody decides they want to just try heroin at a party, and all of a sudden they're addicted. It happens in, in different ways, you know, and the whole fentanyl thing has been so daggum nefarious, right? You know, pushing fentanyl into marijuana. Jay Kopelman: Somebody's smoking a joint and all of a sudden they're addicted to fentanyl or they die. Melissa Lavasani: I think we're having a, Jay Kopelman: it's, it's just not fair to, to say everybody in this pot is the same, or everybody in this one is the same. We have [00:46:00] to look at it differently. Joe Moore: Yeah. I like to zoom one level out and kind of talk about, um, just how hurt we are as a country, as a world really, but as a country specifically, and how many people are out of work for so many. Joe Moore: Difficult reasons and away from their families for so many kind of tragic reasons. And if we can get people back to their families and back to work, a lot of these things start to self-correct, but we have to like have those interventions where we can heal folks and, and get them back. Um, yeah. And you know, everything from trauma, uh, in childhood, you know, adulthood, combat, whatever it is. Joe Moore: Like these things can put people on the sidelines. And Jay, to your point, like you get knee surgery and all of a sudden you're, you know, two years later you're on the hunt for Fentanyl daily. You know, that's tough. It's really tough. Carl Hart does a good job talking about this kind of addiction pipeline and [00:47:00] a few others do as well. Joe Moore: But it's just, you know, kind of putting it in a moral failure bucket. It's not great. I was chatting with somebody about, um, veterans, it's like you come back and you're like, what's gonna make me feel okay right now? And it's not always alcohol. Um, like this is the first thing that made me feel okay, because there's not great treatments and there's, there's a lot of improvements in this kind of like bringing people back from the field that needs to happen. Joe Moore: In my opinion. I, it seems to be shared by a lot of people, but yeah, there's, it's, it's, IGA is gonna be great. It's gonna be really important. I really can't wait for it to be at scale appropriately, but there's a lot of other things we need to fix too, um, so that we can just, you know, not have so many people we need to, you know, spend so much money healing. Joe Moore: Mm-hmm. Jay Kopelman: Yeah. You ahead with that. We don't need the president to sign an executive order to automatically legalize Ibogaine. Right. But it would be nice if he would reschedule it so that [00:48:00] then then researchers could do this research on a larger scale. You know, we could, we could now get some real data that would show the efficacy. Jay Kopelman: And it could be done in a safe environment, you know? And, and so that would be, do Joe Moore: you have any kind of figures, like, like, I've been talking about this for a while, Jay. Like, does it drop the cost a lot of doing research when we deschedule things? Jay Kopelman: I, I would imagine so, because it'll drop the cost of accessing the medicines that are being researched. Jay Kopelman: Right? You, you would have buy-in from more organizations. You know, you might even have a pharma company that comes into this, you know, look at j and j with the ketamine, right? They have, they have a nasal spray version of ketamine that's doing very well. I mean, it's probably their, their biggest revenue [00:49:00] provider for them right now. Jay Kopelman: And, and so. You know, you, it would certainly help and I think, I think it would lower costs of research to have something rescheduled rather than being schedule one. You know it, people are afraid to take chances when you're talking about Schedule one Melissa Lavasani: labs or they just don't have the money to research things that are on Schedule one. Melissa Lavasani: 'cause there's so much in an incredible amount of red tape that you have to go through and, and your facility has to be a certain way and how you contain those, uh, medicines. Oh, researching has to be in a specific container and it's just very cumbersome to research schedule one drugs. So absolutely the cost would go down. Melissa Lavasani: Um, but Joe Moore: yeah, absolutely. Less safes. Melissa Lavasani: Yeah. Joe Moore: Yes. Less uh, Melissa Lavasani: right. Joe Moore: Locked. Yeah. Um, it'll be really interesting when that happens. I'm gonna hold out faith. That we can see some [00:50:00] movement here. Um, because yeah, like why make healing more expensive than it needs to be? I think like that's potentially a protectionist move. Joe Moore: Like, I'm not, I'm not here yet, but, um, look at AbbVie's, uh, acquisition of the Gilgamesh ip. Mm-hmm. Like that's a really interesting move. I think it was $1.2 billion. Mm-hmm. So they're gonna wanna protect that investment. Um, and it's likely going to be an approved medication. Like, I don't, I don't see a world in which it's not an approved medication. Joe Moore: Um, you know, I don't know a timeline, I would say Jay Kopelman: yeah. Joe Moore: Less than six years, just given how much cash they've got. But who knows, like, I haven't followed it too closely. So, and that's an I bga derivative to be clear, everybody, um mm-hmm. If you're not, um, in, in the loop on that, which is hopeful, you know? Joe Moore: Mm-hmm. But I don't know what the efficacy is gonna be with that compared to Ibogaine and then we have to talk about the kind of proprietary molecule stuff. Um, there's like a whole bunch of things that are gonna go on here, and this is one of the reasons why I'm excited about. Federal involvement [00:51:00] because we might actually be able to have some sort of centralized manufacturer, um, or at least the VA could license three or four generic manufacturers per for instance, and that way prices aren't gonna be, you know, eight grand a dose or whatever. Joe Moore: You know, it's, Jay Kopelman: well, I think it's a very exciting time in the space. You know, I, I think that there's the opportunity for innovation. There is the opportunity for collaboration. There's the opportunity for, you know, long-term healing at a very low cost. You know, that we, we have the highest healthcare cost per capita in the world right here in the us. Jay Kopelman: And, and yet we are not the number one health system in the world. So to me, that doesn't add up. So we need to figure out a way to start. Bringing costs down for a lot of people and [00:52:00] at the same time increasing, increasing outcomes. Joe Moore: Absolutely. Yeah. There's a lot of possible outcome improvements here and, and you know, everything from relapse rates, like we hear often about people leaving a clinic and they go and overdose when they get home. Tragically, too common. I think there's everything from, you know, I'm Jay, I'm involved in an organization called the Psychedelics and Pain Association. Joe Moore: We look at chronic pain very seriously, and IGA is something we are really interested in. And if. We could have better, you know, research, there better outcome measures there. Um, you know, perhaps we can have less people on opioids to begin with from chronic pain conditions. Um, Jay Kopelman: yeah, I, I might be due for another Ibogaine journey then, because I deal with chronic pain from Jiujitsu, but, Joe Moore: oh gosh, let's Jay Kopelman: talk Joe Moore: later. Jay Kopelman: That's self inflicted. Some people would say take a month off, but Melissa Lavasani: yeah, Jay Kopelman: I'm [00:53:00] not, I'm not that smart. Joe Moore: Yeah. Um, but you know, this, uh, yeah, this whole thing is gonna be really interesting to see how it plays out. I'm endlessly hopeful pull because I'm still here. Right. I, I've been at this for almost 10 years now, very publicly, and I think we are seeing a lot of movement. Joe Moore: It's not always what we actually wanna see, but it is movement nonetheless. You know, how many people are writing on this now than there were before? Right. You know, we, we have people in New York Times writing somewhat regularly about psychedelics and. Even international media is covering it. What do we have legalization in Australia somewhat recently for psilocybin and MDMA, Czech Republic. Joe Moore: I think Germany made some moves recently. Mm-hmm. Um, really interesting to see how this is gonna just keep shifting. Um Jay Kopelman: mm-hmm. Joe Moore: And I think there's no way that we're not gonna have prescription psychedelics in three years in the United States. It pro probably more like a [00:54:00] year and a half. I don't know. Do you, are you all taking odds? Melissa Lavasani: Yeah. I mean, I think Jay Kopelman: I, I gotta check Cal sheet, see what they're saying. Melissa Lavasani: I think it's safe to say, I mean, this could even come potentially the end of this year, I think, but definitely by the end of 2027, there's gonna be at least one psychedelic that's FDA approved. Joe Moore: Yeah. Yeah. Melissa Lavasani: If you're not counting Ketamine. Joe Moore: Right. Jay Kopelman: I, I mean, I mean it mm-hmm. It, it doesn't make sense that it. Shouldn't be or wouldn't be. Right. The, we've seen the benefits. Mm-hmm. We know what they are. It's at a very low cost, but you have to keep in mind that these things, they need to be done with the right set setting and container. Right. And, and gotta be able to provide that environment. Jay Kopelman: So, but I would, I would love, like I said, I'd love to work myself out of a job here and see this happen, not just for our veterans, [00:55:00] but for everybody. Joe Moore: Mm-hmm. Um, so Melissa, is there a way people can get involved or follow PMC or how can they support your work at PMC? Melissa Lavasani: Yeah, I mean, follow us in social media. Melissa Lavasani: Um, our two biggest platforms are LinkedIn and Instagram. Um, I'm bringing my newsletter back because I'm realizing, um, you know, there is a big gap in, in kind of like the knowledge of Washington DC just in general. What's happening here, and I think, you know, part of PC's value is that we're, we are plugged into conversations that are being had, um, here in the city. Melissa Lavasani: And, you know, we do get a little insight. Um, and I think that that would really quiet a lot of, you know, the, a lot of noise that, um, exists in the, our ecosystem. If, if people just had some clarity on like, what's actually happening or happening here and what are the opportunities and, [00:56:00] um, where do we need more reinforcement? Melissa Lavasani: Um, and, and also, you know, as we're putting together public education campaign, you know. My, like, if I could get everything I wanted like that, that campaign would be this like multi-stakeholder collaborative effort, right? Where we're covering all the ground that we need to cover. We're talking to the patient groups, we're talking to traditional mental health organizations, we're talking to the medical community, we're talking to the general population. Melissa Lavasani: I think that's like another area that we, we just seem to be, um, lacking some effort in. And, you know, ultimately the veteran story's always super compelling. It pulls on your heartstrings. These are our heroes, um, of our country. Like that, that is, that is meaningful. But a lot of the veteran population is small and we need the, like a, the just.[00:57:00] Melissa Lavasani: Basic American living in middle America, um, understanding what psychedelics are so that in, in, in presenting to them the stories that they can relate to, um, because that's how you activate the public and you activate the public and you get them to see what's happening in these clinical trials, what the data's been saying, what the opportunities are with psychedelics, and then they start calling their members of Congress and saying, Hey, there is this. Melissa Lavasani: Bill sitting in Congress and why haven't you signed onto it? And that political pressure, uh, when used the right way can be really powerful. So, um, I think, you know, now we're at this really amazing moment where we have a good amount of congressional offices that are familiar enough with psychedelics that they're willing to move on it. Melissa Lavasani: Um, there's another larger group, uh, that is familiar with psychedelics and will assist and co-sponsor legislation, but there's still so many offices that we haven't been able to get to just 'cause like we don't have all the time in the world and all the manpower in the world to [00:58:00] do it. But, you know, that is one avenue is like the advocates can speak to the, the lawmakers, the experts speak to the lawmakers, and we not, we want the public engaged in this, you know, ultimately, like that's. Melissa Lavasani: Like the best form of harm reduction is having an informed public. So we are not, they're not seeing these media headlines of like, oh, this miracle cure that, um, saved my family. It's like, yes, that can happen psychedelics. I mean, person speaking personally, psychedelics did save my family. But what you miss out of that story is the incredible amount of work I put into myself and put into my mental health to this day to maintain, um, like myself, my, my own agency and like be the parent that I wanna be and be the spouse that I wanna be. Melissa Lavasani: So, um, we, we need to continue to share these stories and we need to continue to collaborate to get this message out because we're all, we're all in the same boat right now. We all want the same things. We want patients to have safe and [00:59:00] affordable access to psychedelic assisted care. Um, and, uh. We're just in the beginning here, so, um, sign up for our newsletter and we can sign up on our website and then follow us on social media. Melissa Lavasani: And, um, I anticipate more and more events, um, happening with PMC and hopefully we can scale up some of these events to be much more public facing, um, as this issue grows. So, um, I'm really excited about the future and I'm, I've been enjoying this partnership with Mission Within. Jay is such a professional and, and it really shows up when he needs to show up and, um, I look forward to more of that in the future. Joe Moore: Fantastic. And Jay, how can people follow along and support mission within Foundation? Jay Kopelman: Yeah, again, social media is gonna be a good way to do that. So we, we are also pretty heavily engaged on LinkedIn and on Instagram. Um, I do [01:00:00] share, uh, a bit of my own stuff as well. On social media. So we have social media pages for Mission within Foundation, and we have a LinkedIn page for mission within foundation. Jay Kopelman: I have my own profiles on both of those as well where people can follow along. Um, one of the other things you know that would probably help get more attention for this is if the general public was more aware of the numbers of professional athletes who are also now pursuing. I began specifically to help treat their traumatic brain injuries and the chronic traumatic encephalopathy that they've, uh, suffered as a result of their time in professional sports or even college sports. Jay Kopelman: And, you know. I people worship these athletes, and I [01:01:00] think that if more of them, like Robert Gall, were more outspoken about these treatments and the healing properties that they've provided them, that it would get even more attention. Um, I think though what Melissa said, you know, I don't wanna parrot anything she just said because she said it perfectly Right. Jay Kopelman: And I'd just be speaking to hear myself talk. Um, but being collaborative the way that we are with PMC and with Melissa is I think, the way to move the needle on this overall. And like she said, if she could get more groups involved in, in these discussions, it would, it would do wonders for us. Joe Moore: Well, thank you both so much for your hard work out there. I always appreciate it when people are showing up and doing this important, [01:02:00] sometimes boring and tedious, but nevertheless sometimes, sometimes exciting work. And um, so yeah, just thank you both and thank you both for showing up here to psychedelics today to join us and I hope we can continue to support you all in the future. Jay Kopelman: Thank you, Joe. Thank you, Joe. It's a pleasure being with you today and with Melissa, of course, always Melissa Lavasani: appreciate the time and space. Joe Moore: Thanks.  

Read the blog postTL;DR: Toyota's real competitive advantage is not its tools -- it is mutual trust and mutual respect. Leaders are responsible for cultivating both. When trust is present, employees speak up, problems surface early, and continuous improvement accelerates. Without it, Lean becomes mechanical and unsustainable.When executives discuss Toyota, the conversation often centers on tools.Kanban. Andon. Standardized work. A3 thinking.Those matter. But Toyota's sustained performance does not come from tools alone. It comes from the leadership philosophy that makes those tools work.At the center of that philosophy is mutual trust and mutual respect.Not as cultural decoration.As operational necessity.Toyota is explicit: improvement depends on people surfacing problems quickly. That only happens when trust flows in both directions.Toyota's own guiding principles website says they:"Foster a corporate culture that enhances both individual creativity and the value of teamwork, while honoring mutual trust and respect between labor and management."Leaders must trust employees to act responsibly.Employees must trust leaders to respond constructively.Without that reciprocity, performance deteriorates.

One of the hottest topics in college athletics turns out to be about nonprofits. This episode unpacks how nonprofit colleges and third-party NIL collectives support individual student athletes, the governance and tax questions that follow, and what the recent NCAA settlement means for oversight and compliance. We also look ahead to emerging federal regulation and how nonprofits might engage in shaping what comes next.   Attorneys for this Episode ·      Tim Mooney ·      Victor Rivera   Why NIL Is a Nonprofit Issue  ·       Define NIL: athlete rights to monetize their brand (name, image, likeness). ·       Distinguish third-party deals vs. institution-linked compensation ·       Why nonprofits are in the mix: NIL collectives, booster organizations, independent sponsorscirculating capital in the ecosystem. College athletics live inside nonprofit institutions — universities and colleges are almost all 501(c)(3)s. Enter third-party NIL collectives — many of which are also nonprofits, often organized as 501(c)(3)s or seeking that status. When nonprofits move money, governance and tax law always follow — NIL is no exception. In October 2025, a settlement in House v. NCAA settlement centralized review mechanisms (the College Sports Commission – or CSC) now oversee deal approvals & compliance. Ongoing federal intervention: the proposed SCORE Act is NCAA-backed and would stop athletes from being considered employees and shield the NCAA from the kinds of class action lawsuits that got us to the current NIL landscape   How Nonprofits End Up Supporting Individual College Athletes Nonprofits can and do financially benefit specific individuals (scholarships, disaster relief, housing aid, fellowships). NIL collectives operate on a similar theory: Supporting athletes through appearances, community engagement, or promotional activity Often tied (explicitly or implicitly) to institutional athletic programs The tension: Supporting individuals is allowed But private benefit, inurement, and mission drift are still red lines Issue with compensating individuals using their "fair market value" Key question for nonprofits: Are we advancing a charitable purpose (legal) or just subsidizing compensation (questionable)? Governance Questions Nonprofits Can't Ignore Board-level responsibilities Mission alignment How does athlete support further the stated charitable purpose? Is this education, community engagement, economic equity or something else? "Amateur athletics" does a lot of heavy lifting here, but sometimes the collectives compensate the athletes for promoting charitable events/causes. Board oversight Who approves NIL strategy? How are conflicts of interest handled (especially boosters, alumni, donors)? Controls and accountability Criteria for selecting athletes Documentation of services provided Fair market value analysis Transparency What are donors told? What is disclosed publicly vs. internally? Regulation on the Horizon After the NCAA Settlement The NCAA settlement signals: More centralized oversight More formal review of NIL arrangements Less tolerance for "wink-and-nod" structures Likely regulatory pressure points: Standardized deal review Clearer definitions of permissible activity Increased scrutiny of nonprofit status and operations Should Nonprofits Weigh In on What Comes Next? The NCAA settlement last fall quieted things down by creating reporting structures, arguably with some teeth. But as things evolve, there's more space for nonprofits in particular to notice. Will the College Sports Commission (CSC) continue to have conference support so it can enforce the NIL rules? The agreement hasn't been fully adopted yet, but the CSC is already knocking down some NIL deals. Federal legislation (SCORE Act or SAFE Act) Recent controversies surrounding eligibility of former pro-basketball players (Amari Bailey, Charles Bediako) may force Congress to act NCAA-adjacent rulemaking State-level NIL frameworks particularly regarding their institutions Other structures could allow potential pathways for unionization for student-athletes 501(c)(5)s like AFL-CIO have come out against SCORE Act Previous attempts have failed by student-athletes in Northwestern and in other universities and the SCORE Act has a provision that bans college athletes from being considered employees Resources NIL Compliance Tightens: What the NCAA's New Rules Mean for Institutions and Sponsors – Steptoe and Johnson College Sports Watchdog Will Enforce Rules Without Legal Backing – Front Office Sports NIL regulations for college athletes face hurdles in Congress – Spectrum News Letter Opposing Legislation That Would Be A Bad Deal for College Athletes – AFL-CIO

In this episode of The Dish on Health IT, host Tony Schueth is joined by co-host Alix Goss and special guest Amy Gleason, Strategic Advisor to Centers for Medicare & Medicaid Services (CMS) and Administrator of the U.S. Department of Government Efficiency (DOGE) Service, for a wide-ranging discussion on how health IT modernization is evolving under a pledge-driven, incentive-backed federal strategy.The conversation begins not with policy, but with lived experience.From Emergency Room to Interoperability AdvocateAmy shares how her early career as an emergency room nurse exposed the dangers of fragmented information. Providers were expected to make critical decisions without access to complete patient histories, while patients, often in pain or distress, were unrealistically asked to recall complex medical details.That professional frustration became deeply personal when her daughter went more than a year without diagnosis for a rare autoimmune disease, juvenile dermatomyositis (JDM). Multiple specialists saw pieces of the puzzle, but no one could see the full picture across charts and settings. Amy reflects that if today's AI tools had been applied to her daughter's complete longitudinal record, the condition may have surfaced sooner.That experience shaped her philosophy. Technology must converge with policy and trust in ways that tangibly improve care.Why Pledges Instead of Rules?Tony presses on a central theme. Amy has argued that we cannot regulate our way to success. Why pursue voluntary pledges instead of federal rulemaking?Amy explains her frustration returning to government in 2025 to find interoperability policies she helped draft in 2020 still not fully effective until 2027. Seven years is an eternity in technology. Meanwhile, the industry had technically complied with numerous mandates including Meaningful Use, Cures Act APIs and CMS interoperability rules, yet many workflows still felt broken.In her view, regulation created a floor but not always real transformation.The CMS Health Tech Ecosystem Pledge was launched as a different model. The federal government used its convening power to articulate a clear vision and challenge industry to deliver minimum viable products within six to twelve months rather than years.Initially announced with roughly 60 companies, the pledge initiative has grown to more than 600 participants collaborating in working groups. The three initial patient-focused use cases include:Improving data interoperability“Killing the clipboard” through digital identity and QR-based sharingLeveraging conversational AI and personalized recommendations for chronic conditions such as diabetes and obesityAmy describes live demonstrations at a Connectathon showing OAuth-enabled data retrieval, QR ingestion into EHR workflows and AI-powered recommendations built on patient data. The goal is not perfection by the first milestone, but real-world minimum viable functionality that can iteratively improve.Alix notes that from the standards community perspective, this approach feels aligned with long-standing calls for industry-driven collaboration, though it remains early to measure widespread impact.Carrots, Sticks and Rural HealthThe discussion turns to incentives.Amy outlines the administration's carrots and sticks strategy:Stick: Enforcement of information blocking, with penalties up to $2 million per occurrenceCarrots: Financial incentives such as the $50 billion Rural Health Transformation Program and the CMS ACCESS Model, which pays for technology-enabled outcomesThe Rural Health Transformation Program directs money to states with expectations that ecosystem-aligned interoperability and app participation be incorporated into funding proposals. CMS retains oversight and clawback authority to ensure funds support rural providers.The ACCESS Model represents a significant shift. Technology-enabled care platforms can register as Medicare Part B providers and be paid for measurable outcomes in tracks such as cardiometabolic disease, musculoskeletal conditions and behavioral health. Providers remain in the loop and receive compensation for referral and care plan oversight.Alix underscores that rural providers face steep financial and workforce constraints. Standards participation, implementation and technology upgrades require resources that are often scarce. The success of these incentives will depend on whether they reduce burden rather than add to it.AI: Evolution, Risk and RealityAI becomes a central thread of the episode.Amy compares AI adoption to autonomous vehicle models. Some scenarios allow tightly controlled automation, such as medication refills, while others require a human in the loop for higher-risk decisions. She points to a Utah prescription refill pilot as an example of bounded automation, where malpractice coverage and clearly defined use cases mitigate risk.When Tony asks who owns risk in this evolving landscape, Amy emphasizes the need for light but clear regulatory pathways rather than fragmented state-by-state oversight.Patients, she notes, are already there. Millions are asking health-related questions weekly through AI tools. The more pressing issue is ensuring those tools are grounded in structured medical data rather than incomplete memory or unverified inputs.She shares a striking story. Her daughter was excluded from a clinical trial due to a misclassification of ulcerative colitis. By uploading her records into an AI model, they identified a more precise diagnosis, microscopic lymphocytic colitis, which did not disqualify her from the trial. For Amy, this demonstrates both the power and inevitability of AI use.Alix adds caution. AI is only as strong as the data beneath it. Dirty, inconsistent and poorly structured data limits performance. Standards and terminologies remain essential to fuel high-fidelity models and safeguard trust.FHIR, Deregulation and the Data FoundationThe conversation addresses an emerging tension. If regulatory burdens are being reduced, does that signal less need for structured standards like FHIR?Amy candidly admits she initially wondered whether AI might reduce the need for FHIR altogether. After discussions with labs and technologists, she concluded the opposite. Standardized data dramatically improves AI performance and reduces error.Deregulation is about removing unnecessary burden, not abandoning foundational data structures.Alix reinforces that FHIR enables discrete, normalized data capture that supports both legacy transactions and AI evolution. While future innovations may emerge, today FHIR remains the backbone for scalable interoperability.Prior Authorization and HIPAA ModernizationThe episode dives into prior authorization modernization across medical and pharmacy domains.Amy notes growing interest among pledge participants to expand into pharmacy prior authorization testing, diagnostic imaging, real-time benefit checks and bulk FHIR performance testing.Alix provides insight into ongoing work within the Designated Standards Maintenance Organizations to incorporate FHIR-based approaches into HIPAA-named standards, particularly for prior authorization. She highlights testing beyond Connectathons, including implementer communities and real-world pilot efforts.Both stress the importance of public comment periods and industry engagement, describing participation as a civic responsibility for health IT professionals.Trust as the Core EnablerThe final segment centers on trust.Amy explains that the ecosystem initiative aims to reinforce trust through:Stronger digital identity verification such as Clear, ID.me and Login.govCertification frameworks such as CARIN and DIME for patient-facing appsA new national provider directory to replace fragmented provider data sourcesTransparency dashboards showing data requests, volumes and purposeRather than replacing frameworks like TEFCA, she describes the pledge model as an accelerator layered above the regulatory floor.Transparency acts as sunlight, enabling visibility into who is accessing data and for what purpose.Final TakeawaysIn closing, Amy urges providers not to sit on the sidelines. Too often, she says, providers feel change is imposed on them. The pledge environment is designed as an open forum where they can directly shape what works or does not work in real workflows.Alix echoes the call. Standards require participation. Organizations must allocate budget and staff to engage, comment and collaborate. It truly takes a village.Tony concludes by framing the episode's core message. Regulation establishes baseline expectations, but voluntary movements can demonstrate what is possible before mandates reach the Federal Register.Across pledges, payment reform, AI evolution and trust frameworks, the episode underscores a consistent theme. Modernization in health IT depends not only on policy direction, but on shared accountability and active participation from every stakeholder in the ecosystem.Listeners are reminded that POCP is available to support organizations in understanding the implications of federal initiatives, enforcement priorities and their strategic implications. Reach out to us to set up an initial consultation. The episode closes, as always, with the reminder that Health IT is a dish best served hot.Prefer video? Catch episodes on the POCP YouTube channel

In 2015, Jeremy Tate embarked on a mission to provide alternative standardized tests rooted in tradition. It all began when Jeremy questioned how American education had come to be so utilitarian, realizing that transcendent, moral, and ethical ideas had been gutted from the classroom. He came to the conclusion that high-stakes testing was partially to blame, driving secondary school curriculum. David Coleman, CEO of the College Board, has stated publicly that “teachers will teach towards the test. There is no force on this earth strong enough to prevent that.” If teaching to the test is an inescapable reality, then shouldn't those tests engage students with the thinkers and writings that have most meaningfully shaped history and culture?  Historically, the goal of education has been understood as developing both intellect and character in students. Its purpose was to help students become better human beings. Standardized tests should reflect that same goal. They should leave students feeling inspired and enriched while equipping them to pursue their goals. That's why our tests feature beautiful and meaningful content in addition to assessing timeless academic skills. By offering a new standard for assessments, CLT aims to be a catalyst for renewal in education nationwide.    

Get free access to The Fire Time Magazine every month by going to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.itsfiretime.com/subscribe⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ —— Order the latest issue of the printed Fire Time Journal: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://itsfiretime.com/journal⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Support The Fire Time Podcast financially: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://itsfiretime.com/join⁠⁠⁠⁠⁠ Become an Advertising Partner: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.itsfiretime.com/advertising

Black cumin seed oil has a long history of traditional use, and its benefits trace to thymoquinone. However, it also contains the omega-6 fat linoleic acid (LA), which exposes you to risks that may outweigh its benefits Thymoquinone makes up only about 0.1% to 0.9% of black cumin seed oil, so obtaining meaningful amounts through this oil requires consuming substantial quantities of LA Black cumin seed oil contains roughly 50% to 62% LA by weight, placing it in the same high-LA category as other vegetable oils, such as cottonseed oil Typical dosing of 1 to 3 teaspoons daily delivers roughly 2.5 to 7.5 grams of LA, representing a meaningful increase over an already elevated modern baseline intake Standardized thymoquinone extracts are a better alternative, commonly sold as 5%, 10%, or 20% formulations. These allow you to obtain benefits from a traditional remedy without the LA burden

Burnie and Ashley discuss perfect months, Olympic flaps, luggage weight, Lego Haily Mary, showing kids old stuff, Dispatch censorship, Dungeon Crawler Carl, spoiler etymology, Quick Resume, and Winter Olympics Opening Ceremony.

7-ELEVEN (TO-7-FROM-11)•Ordering higher on new books than 2025. •IRON MAN #1 is a good comic! •7-11!  •Consignment issues. •Collecting comic art we're on. •Thanks, Patrons! •Standardized comic data. •Hirayasumi is a delightful manga!   This episode is dedicated to Our Pal Sal, Sal Buscema. Thank you, Sal. Tell John we miss him. ---------- Contest of Challengers #765 Theme: Adam WarRock (with Mikal kHill) Intro: James VanOsdol (with Chris Jericho) Outro: James VanOsdol "Patrick" Voices: Richie Kotzen, Christopher Daniels, James Acaster, Sue Marasciulo (Trent's Mom), RJ City, Sebastian Bach, Arune Singh, James VanOsdol "Dal" Voices: James VanOsdol, RJ City, Dalton Castle, Sue Marasciulo (Trent's Mom), Kevin Conroy, Kris Statlander, Skye Blue, Bryce Remsberg, Arune Singh Dal and Patrick Artwork: Bella Spagnuolo https://bellaspagnuoloart.myportfolio.com/ This episode was digitally edited by Cleanvoice. ----------Challengers Comics + Conversation 1845 N Western Ave • Chicago, IL 60647 773.278.0155 • ChallengersComics.com

AMDG. Standardized testing is a minefield for parents and students, but it does not have to be. Kolbe alum Colin and current Kolbe senior Tobias join the Kolbecast to share their firsthand experiences taking the ACT, SAT, CLT, and PSAT. The duo explains the differences between the tests, breaks down how scoring works, and shares the study strategies that helped them succeed. Whether you are a parent guiding your child through the testing process or a student preparing for your first exam, this episode is a must-listen.   Links mentioned & relevant:  Taking the Classic Learning Test (CLT) as a Kolbe student  College Entrance & AP Exams article in Kolbe Academy Help Center  Career Guidance & Discernment section of Kolbe Academy Help Center (including college planning)  College Planning Timeline  College Planning section of Kolbe Academy website  Related Kolbecast episodes:  265 Chosen to Be a Saint, Commencement 2025 speeches including from Colin Lengyel and Brendan Murphy  163 Postcards from France  193 STEM, State Schools, and Sibling Dynamics   38 Substance Matters with Classic Learning Test founder Jeremy Tate  Have questions or suggestions for future episodes or a story of your own experience that you'd like to share? We'd love to hear from you! Send your thoughts to podcast@kolbe.org and be a part of the Kolbecast odyssey.   We'd be grateful for your feedback! Please share your thoughts with us via this Kolbecast survey!  The Kolbecast is available on Apple Podcasts, Spotify, and most podcast apps. By leaving a rating and review in your podcast app of choice, you can help the Kolbecast reach more listeners. The Kolbecast is also on Kolbe's YouTube channel (audio only with subtitles).  Using the filters on our website, you can sort through the episodes to find just what you're looking for. However you listen, spread the word about the Kolbecast! 

Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826251393909

American college students can't do basic math – and the problem didn't start in college. In this episode of The Deep, Erika breaks down shocking new data from UC San Diego, exposes how grade inflation and dishonest standards hollowed out education, and explores whether the “Mississippi Miracle” is the solution to America's math crisis.Timestamps:0:00 - Intro: college freshman lack high-school math skills2:33 - What the UCSD report uncovered4:18 - Standardized tests and grade inflation7:18 - The system is broken10:07 - Getting at the root to solve the math crisis13:35 - Conclusion: putting the soul back in educationSources:Bloom, Allan. The Closing of the American Mind. New York: Simon & Schuster, 1987.Horowitch, Rose. 2025. “American Kids Can't Do Math Anymore.” The Atlantic, November 19, 2025. Accessed December 5, 2025. https://www.theatlantic.com/ideas/2025/11/math-decline-ucsd/684973/.Piper, Kelsey. 2025. “When Grades Stop Meaning Anything.” The Argument, November 18, 2025. Accessed December 5, 2025. https://www.theargumentmag.com/p/when-grades-stop-meaning-anything. theargumentmag.comRawat, Saannidhya, and Vikram K. Suresh. 2024. GPT Takes the SAT: Tracing Changes in Test Difficulty and Students' Math Performance. SSRN Working Paper, August 3, 2024. Accessed December 5, 2025. https://papers.ssrn.com/abstract=4915452. SSRNSalzman, Matthew, and Tyler Cowen. 2024. “Math, SAT Scores May Be Doing Worse Than We Had Thought.” Marginal Revolution, August 2024. Accessed December 5, 2025. https://marginalrevolution.com/marginalrevolution/2024/08/math-sat-scores-may-be-doing-worse-than-we-had-thought.html.

Medicare doesn't have to be confusing. In this episode, we break down Medigap standardization and reveal how plans with the same letter offer identical benefits, no matter the company. Learn how this system protects you from surprise gaps in coverage and empowers you to choose confidently, knowing exactly what you're getting for your healthcare needs. 

Happy 2026! Time to dust off the crystal ball.Will we finally get standardized measurement? Will podcasters still pick video over audio? How should you navigate a seller's market?Find out as we make big, bold (and accurate) predictions for 2026. All on a new Media Roundtable: Special Edition.Dan Granger (CEO & Founder, Oxford Road) welcomes back a stacked team of podcast nostradamuses:Hernan Lopez, (Founder of Owl & Co)James Cridland (Editor, Podnews & Podcast Business Journal)Kyle Jelinek, (VP of Client Services, Oxford Road)Neal Lucey, (EVP, Strategy & Product, Oxford Road)They're talking: Audio's Rise, Standardization (Finally!), Seller's Markets, and more. Let's dig in.“ My prediction is: the buyer's market has officially ended.”Neal Lucey, (EVP, Strategy & Product, Oxford Road)See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

TALK TO ME, TEXT ITThe holidays are finally over and the world feels like it's snapping back into place—shows return, routines resume, and the coffee hits just right. From that grounded moment, we wade into three stories that capture how people search for magic, beauty, and value in a noisy year. First up: the rise of fantasy‑core baby names—think romance epics, viral book series, and anime fueling a wave of Alistairs and Cordelias. We talk about why parents are chasing myth and nostalgia, how social media accelerates naming cycles, and whether a dramatic name helps a child carry story or just chases a trend.Then we pivot to the jaw‑clencher: fillers made from donated cadaver fat used for Brazilian butt lifts and breast enhancements. We sift through the medical pitch—sterile processing, minimally invasive injections, access for thinner patients—alongside the gut‑level ethics and consent questions. What does “beauty at any cost” mean when the supply chain starts in a morgue? We make the case for caution, long‑term safety data, and choosing dignity over fast results that mirror the lifespan of a viral reel.Finally, we break down McDonald's 2026 shift toward more consistent pricing and expanded rewards. Standardized price guidance could tame the location‑to‑location sticker shock, while loyalty programs sweeten value and tie customers to the app. It's a classic trade: smoother tech and predictable costs versus less human contact at the counter. For anyone feeling squeezed by inflation, these changes hint at how big brands will court trust this year—through clarity, not just coupons.Underneath it all runs a simple theme: the pull between escapism and stability. Names borrow wonder; beauty trends push limits; fast food promises order. We end by checking back in on home base—taking down decorations, settling into a rhythm, and choosing the slow, sturdy options when the world is loud. If this mix of cultural trends, ethics, and everyday choices speaks to you, follow the show, share it with a friend, and leave a quick review to tell us which story surprised you most.Buzzsprout - Let's get your podcast launched!Start for FREE Thanks for listening! Liberty Line each week on Sunday, look for topics on my X file @americanistblog and submit your 1-3 audio opinions to anamericanistblog@gmail.com and you'll be featured on the podcast. Buzzsprout - Let's get your podcast launched!Start for FREESupport the showTip Jar for coffee $ - Thanks Music by Alehandro Vodnik from Pixabay Blog - AnAmericanist.comX - @americanistblog

Greg Brady talked to Paul Bennett, director of the Schoolhouse Institute and a senior fellow of the Macdonald-Laurier Institute, about why provincial testing agencies must be strengthened, how test results guide meaningful improvements, and what it means for parents and teachers when transparency in education is lost Learn more about your ad choices. Visit megaphone.fm/adchoices

Greg Brady talked to Paul Bennett, director of the Schoolhouse Institute and a senior fellow of the Macdonald-Laurier Institute, about why provincial testing agencies must be strengthened, how test results guide meaningful improvements, and what it means for parents and teachers when transparency in education is lost Learn more about your ad choices. Visit megaphone.fm/adchoices

As we close out 2025, we're wrapping up more than just a year. This episode marks the conclusion of the Machine Shop MBA series, a collaboration with CLA and Modern Machine Shop built around insights from the Top Shops benchmarking program. What started as a practical exploration of shop metrics ends with a much bigger question: what truly separates shops that survive from shops that endure? For this final chapter, we're joined again by Brent Donaldson of Modern Machine Shop, who helped kick off the series earlier in the year. Drawing from hundreds of shop visits and years of benchmarking data, Brent helps us connect the dots across operations, finance, leadership, and strategy. Together, we reflect on a clear shift happening across manufacturing: moving away from pure "rise and grind" thinking and toward intentionally designed systems. Throughout the episode, we revisit five deceptively simple questions pulled directly from the Top Shops survey. These questions challenge assumptions and expose where real opportunity lives. From RFQ response time and revenue per employee to reinvestment discipline, standardized scheduling, and succession planning, each one reinforces a central theme we've explored all year. Rather than chasing the next machine or relying on one big customer, the most resilient shops we see are building repeatable processes, measuring what matters, and reducing dependence on tribal knowledge. This conversation serves as both a reflection on what we've learned through the Machine Shop MBA series and a call to action as we head into 2026. If there's one takeaway we hope sticks, it's this: the shops that last aren't just collections of people and equipment. They are systems. Designed on purpose. Improved on purpose. And built to outlast any one individual. Segments (0:00) Wrapping up 2025 and closing out the Machine Shop MBA series (0:36) Why we created the series and partnered with CLA and Modern Machine Shop (2:25) Why you need to head to the 2026 IMTS Exhibitor Workshop (4:34) The shift from viewing shops as machines and people to viewing them as systems (7:52) Moving from survival mode to disciplined, systems-based thinking (12:33) Top Shops Question #1: RFQ response time as a competitive advantage (15:55) Top Shops Question #2: Revenue per employee as a true efficiency metric (17:15) What's Your Method? The unique financing process with Methods Machine Tools (26:47) Grow your top and bottom line with CliftonLarsonAllen (CLA) (27:37) How automation, workholding, and systems increase output per person (32:16) Top Shops Question #3: Reinvesting in equipment, software, and training (36:50) Why consistent reinvestment beats sporadic big spending (37:51) Top Shops Question #4: Standardized scheduling versus tribal knowledge (40:22) How poor systems create stress and constant firefighting (43:05) Top Shops Question #5: Leadership and ownership transition planning (46:01) The Top Shops 2026 Benchmarking survey opens February 1st, 2026 (47:27) How benchmarking accelerates maturity and reveals real gaps (48:19) How we use the Top Shops survey as part of annual strategic planning (49:19) Looking ahead to 2026 and continued collaboration (50:00) Why we love the SMW Autoblok catalog and quality (51:11) Final call to action and why benchmarking matters Resources mentioned on this episode Why you need to head to the 2026 IMTS Exhibitor Workshop What's Your Method? The financing process with Methods Machine Tools The Top Shops 2026 Benchmarking survey opens February 1st, 2026 Check out the SMW Autoblok catalog and quality Connect With MakingChips www.MakingChips.com On Facebook On LinkedIn On Instagram On Twitter On YouTube

Most companies do a few AI trainings, run some pilots, and then stall. In this episode, host Susan Diaz argues the only real future-proofing strategy is continuous AI literacy. She breaks down what "continuous literacy" actually includes (skill, judgment, workflow, norms), the predictable failure modes of the AI literacy divide, and a simple flywheel you can run monthly so capability keeps compounding. Episode summary Susan opens with a familiar pattern: a burst of AI excitement, a deck called "AI Strategy 2025" a few clever workflows… and then reality hits. Tools change. Policies shift. Vendors overpromise. Early adopters keep learning. Everyone else stalls. Her reframe is blunt: AI is not a project or a software rollout. It behaves like a language. Best practices change fast. What was smart six months ago can become a bad habit in the next six months. So future-proofing isn't about predicting what AI will do next. It's about building an organization that can keep learning without burning people out or gambling with risk. That's what continuous AI literacy is. Key takeaways Continuous AI literacy has four parts: Skill: how to use AI. Judgment: whether you should use AI. Workflow: where AI fits into the process. Norms: what's safe, allowed, expected (guardrails + governance). If training only focuses on skill, you get chaos. If it covers all four, you get adoption velocity without panic. The AI literacy divide is already here. A few people sprint. Most people watch. Leadership tries to govern what they don't fully understand. HR is stuck between "train everyone" and "we have no time". That divide creates three predictable outcomes: Shadow AI (people use tools quietly because they fear bans). Innovation theatre (lots of activity, little operational change). Champion burnout (early adopters carry the organisation and get exhausted). To future-proof, you need a continuous literacy flywheel. Not a one-off workshop. A system. Susan's flywheel starter kit (run it monthly/quarterly): Build the floor: minimum viable competence for everyone (basics of prompting, privacy, verification). Role-based lifts: train people to do their jobs better with AI (sales, HR, marketing, ops), not "AI training" in the abstract. Protect and pay champions: office hours, workflow library, recognition, and compensation so they don't become unpaid internal consultants. Package workflows: move beyond prompting into templates, SOPs, and personalized tools (repeatable cognitive automation). Measure better metrics: stop obsessing only over time saved. Track quality, speed to opportunity, risk reduction, and learning. Refresh the loop: update what changed in tools/policy, what workflows are now standard, and what failure modes to avoid. Repeat. How you know it's working: You'll hear the language change. Less "AI is scary." More "Is this a good use case?" "What's the risk?" "What's the verification step?" AI becomes boring in the best way. Standardized quality improves. Handoffs improve. Fewer heroics. A simple rubric for "good AI use": Is it safe (data + context)? Is the output verifiable? Is a human accountable? Is it repeatable enough to operationalise? Timestamps 00:02 — The pattern: training + excitement + pilots… then stall 00:28 — Vendor "agents" promises and why reality disappoints 01:09 — The only real future-proofing strategy: continuous literacy 02:06 — Reframe: AI is a language, not a project 03:50 — What continuous literacy means in practice 04:11 — The four parts: skill, judgment, workflow, norms 05:40 — Why skill-only training creates chaos 06:05 — Culture as the OS: why literacy won't stick without safety 06:35 — The literacy divide: power users sprint, others stall 07:36 — The three outcomes: shadow AI, innovation theatre, champion burnout 08:24 — Continuous literacy as a flywheel (system, not workshop) 09:02 — Step 1: build the floor (minimum viable competence) 09:58 — Step 2: role-based lifts (train jobs, not "AI") 10:47 — Step 3: champions, guardrails, office hours, and compensation 11:27 — Step 4: workflow packaging (templates, SOPs, personalised tools) 12:21 — Step 5: better metrics beyond time saved 12:50 — Step 6: refresh the loop and repeat 13:49 — How you'll know it's working: language shifts, "boring wins" 14:57 — A simple rubric: safe, verifiable, accountable, repeatable 15:42 — A practical start: 60 minutes of literacy review weekly 16:39 — Close: tools expire, literacy compounds   If you want a future-proof organization, don't build a crystal ball. Build a loop. Start this week with: 60 minutes of literacy review (what changed, what worked, what failed). Pick one workflow to package into a template or SOP. Schedule office hours so learning stays alive. Tools will expire. Literacy will compound.

Justine Lackey built a sellable bookkeeping firm by staying hyper focused on one service, one platform, recurring revenue, documented systems, and ethical leadership. Long before selling in 2023, her firm was structured to operate independently, making the transition successful for clients, employees, and buyers.   Key Takeaways Focused service offerings help firms stand out in M&A discussions Recurring prepaid revenue improves cash flow stability Standardized systems support smoother transitions Ethical leadership enables better client and team outcomes during exits Reducing owner dependency supports long-term firm continuity

In this episode of Skin Anarchy, Dr. Ekta Yadav sits down with Michele Henry, founder and CEO of FACE FOUNDRIÉ, to explore how the facial industry is being quietly—but fundamentally—rewritten. What began as a personal frustration became a scalable solution: professional skincare that's consistent, accessible, and designed for real life, not just special occasions.After her third child, Michele found herself stuck between facials that were either overly luxurious, prohibitively expensive, or wildly inconsistent. She wanted results, education, and efficiency—without the intimidation. When that middle ground didn't exist, she built it. FACE FOUNDRIÉ's facial-bar model challenged long-standing spa norms by focusing exclusively on high-quality facial services delivered quickly, clearly, and consistently.A central theme of the conversation is accessibility. Michele rejects the idea that skincare should feel exclusive or confusing. Transparent pricing and monthly memberships make frequency possible—and frequency, she explains, is what actually drives results. Prestige may impress, but approachability scales.Behind the scenes, FACE FOUNDRIÉ's real innovation is operational. Standardized protocols ensure clients receive the same experience across locations, while personalization comes through targeted enhancements layered on top—not improvisation. Technology tracks treatments and progress, reinforcing consistency as a clinical standard.The episode also tackles a common misconception: that advanced at-home products can replace professional care. Michele makes the case that treatments and products work best together—services like dermaplaning, peels, and extractions create the conditions for skincare to truly perform.At its core, FACE FOUNDRIÉ is about emotional safety as much as skin health. Clients choose how they want to experience their facial—quiet or educational—in spaces designed to feel welcoming, not intimidating.Listen to the full episode to hear how Michele Henry is redefining professional skincare—making results-driven facials scalable, sustainable, and built for everyday life.Learn more about Face Foundarié on their website and social media!CHAPTERS:(0:02) - Introduction & Face Foundrie Overview(0:59) - Michele's Personal Journey & The Origin Story(2:16) - Reimagining the Facial Bar Model(3:23) - Early Trial, Error & Rapid Pivot(5:26) - Accessibility, Memberships & Breaking Prestige Barriers(7:16) - Results-Driven Protocols vs Luxury Spa Experiences(8:23) - Consistency, Personalization & Scalable Systems(10:26) - Franchising Face Foundrie & National Growth(13:35) - Technology, AI & The Future of Skin Care ExperiencesPlease fill out this survey to give us feedback on the show!Don't forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf!*This is a paid collaboration Hosted on Acast. See acast.com/privacy for more information.

Melissa Reider-Demer, DNP, discusses a redesigned discharge workflow that improved inpatient throughput.

Let's be honest,  public school wasn't designed for kids with ADHD. Too often, these kids are labeled, misunderstood, and pushed into systems that don't fit how their brains learn best. But what if the problem isn't your child, but the system itself? In this episode of The Soaring Child Podcast, host Dana Kay, ADHD health practitioner and founder of the ADHD Thrive Method for Kids speaks with Leslie Dernberger, founder of Aspire Education, mom of four, and one of the nation's leading experts in K–12 education for neurodiverse learners. Drawing on her legal background and over a decade of experience helping families, Leslie unpacks why traditional schooling often fails ADHD kids and what parents can do about it. From understanding homeschool laws and navigating deschooling, to structuring the day and busting common misconceptions, this episode is filled with practical guidance and encouragement. Whether you're curious about homeschooling, exploring hybrid options, or just want to better support your child's learning, this conversation will give you hope and actionable tools. Links Mentioned in the Show:▶ Aspire Education: https://www.aspireeducation.us/ ▶ Homeschool Legal Defense Association (HSLDA): https://hslda.org Key Takeaways: [00:00] Public school isn't built for many ADHD learners andwhy fit-the-mold systems backfire. [02:37] Meet Leslie Dirnberger (Aspire Education): mom of four, homeschool veteran, legal background, supports thousands of families. [04:23] The "catalyst event": what finally pushes parents to seek alternatives. [06:03] Spotting the signal: "the spark is gone" and nothing at school is fixing it. [07:16] First steps legally: understand your state's rules; public vs. private education; where homeschooling fits. [10:05] Deschooling 101: reset the parent first; museum/nature learning to reconnect. [13:38] Foundation step: define "a good education" as a family; ask kids what learning should look like. [15:24] Myth-busting socialization: why homeschoolers often get better real-world social practice. [18:30] Colleges love homeschoolers: time management, self-advocacy, executive function. [26:27] Standardized tests miss the mark, especially for ADHD,  focus on mastery instead. Memorable Moments: "The truth is, your child doesn't need to be fixed. They need an education that actually fits their brain." "There is a catalyst event that has occurred that creates a situation that the parents go, wait a second, let's take a step back here." "The spark has gone out, the light has gone out of their eyes and the parents know something's wrong." "The hardest part of homeschooling? Looking myself in the mirror and challenging my own beliefs." "What does a good education look like for your family and for your children?" "Nothing could be further from the truth — homeschoolers are often better socialized." "Colleges love homeschoolers because they know how to manage their time and advocate for themselves." "Accreditation is a game. It is absolutely garbage. It doesn't mean a thing." "Everything is geared towards standardized testing in government schools. And that's why they're in a box and they ram it through, which is terrible for ADHD kids." "Your children can own their own education and advocate for themselves at school." Dana Kay Resources:

The smell of fresh wax, the rumble of arrivals, and a table full of hot takes—our live remote at Gulf Coast Auto Shield pulls you straight into car culture. We kick off with a clear-eyed look at November's sales story: Hyundai dips, Kia climbs, inventory loosens to a 64‑day supply, and hybrids keep humming while EV demand wobbles with changing incentives. That sets the stage for what drivers actually feel on the ground: access, reliability, and the difference between spec sheets and street reality.Nothing gets more real than trying to charge an EV and finding every solution blocked. We walk through a week of charging drama—Tesla‑standard plugs, restricted dealership chargers, public stations reserved by policy or simply clogged by rental fleets—and what it reveals about infrastructure etiquette, operator rules, and the urgent need for better enforcement. Standardized connectors are a win, but adoption hinges on consistent access, uptime, and simple on‑site logic that respects drivers' time.We shift gears into community and performance. Tailpipes & Tacos returns with a toy drive, free breakfast tacos, and a kids' pedal car show, proving that local meets might be the industry's best ambassadors. The Houston Auto Show follows with a holiday BOGO ticket deal and a chance to explore new models without pressure. On the performance front, Stellantis reignites muscle with the gasoline‑powered Dodge Charger Six‑Pack, a straight‑six pumping 550 horsepower, while Cadillac's looming F1 debut adds a fresh storyline to the racing calendar. We round out with Consumer Reports' reliability rankings—Toyota retakes the crown, Subaru and Lexus close behind—and a tour through auto history from Studebaker to Corvair and Jeep's global Compass, topped with shop‑floor memories of body‑by‑Fisher craft.Join us for the mix that keeps enthusiasts hooked: market insight, hands‑on EV lessons, racing heat, reliability you can bank on, and events that welcome everyone. If you're in Houston, bring an unwrapped toy, grab a taco, and say hi. Prefer to ride along from home? Subscribe, share the show with a friend, and drop a review telling us your most frustrating or most satisfying charging experience—what would you fix first?Be sure to subscribe for more In Wheel Time Car Talk!The Lupe' Tortilla RestaurantsLupe Tortilla in Katy, Texas Gulf Coast Auto ShieldPaint protection, tint, and more!Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.---- ----- Want more In Wheel Time car talk any time? In Wheel Time is now available on Audacy! Just go to Audacy.com/InWheelTime where ever you are.----- -----Be sure to subscribe on your favorite podcast provider for the next episode of In Wheel Time Podcast and check out our live multiplatform broadcast every Saturday, 10a - 12nCT simulcasting on Audacy, YouTube, Facebook, Twitter, Twitch and InWheelTime.com.In Wheel Time Podcast can be heard on you mobile device from providers such as:Apple Podcasts, Amazon Music Podcast, Spotify, SiriusXM Podcast, iHeartRadio podcast, TuneIn + Alexa, Podcast Addict, Castro, Castbox, YouTube Podcast and more on your mobile device.Follow InWheelTime.com for the latest updates!Twitter: https://twitter.com/InWheelTimeInstagram: https://www.instagram.com/inwheeltime/https://www.youtube.com/inwheeltimehttps://www.Facebook.com/InWheelTimeFor more information about In Wheel Time Podcast, email us at info@inwheeltime.com

Lex is decking the halls. Sean searches for mistletoe. No, wait. That is later in the month. Right now, housing is the talk of the town! Midnight continues to develop with news that is giving Sean reason to cheer. The schedule for season 1 of Midnight is revealed as Sean worries for the poor 0.1%. News Housing 1st Impressions The talk of the town is the town as Warcraft early access opens up to all who have purchased the upcoming Midnight expansion. Links Housing Early Access Trailer | World of Warcraft: MidnightWhat's Next for WoW Housing? Interview with Devs Jay Hwang and Garth DeAngelis 11.2.7 is Here The prologue to the midnight expansion is live in NA and EU. Midnight Prologue CampaignRevamped New and Returning Player ExperienceLorewalking: ElvesPandaren Heritage ArmorTurbulent Timeways (through to Feb 9th)Brawler's Guild (Next Week) Links https://worldofwarcraft.blizzard.com/en-us/news/2424444211.2.7 The Warning Launch Trailer | World of Warcraft Dungeon Philosophy in Action Changes to the dungeons begin reflecting the team's new philosophies. Standardized short castImportant casts with 4 sec or greater cast timeReduced number of castersBolt-slop reduced damageAnti Focus Fire behaviorCast Audio Notification (player and target) Links New Interrupt Philosophy Showcased in Midnight's Mythic+ Testing - Wowhead News Seeing Red Combat Addons are still allowed to provide a competitive advantage as Blizzard reneges on the entire reason for the addon de-escalation. Through a use of conditionals Platynator was able to color code:BossesLieutenantsCastersMeleeMinor enemiesCasters would only change to their colour when they first cast an interruptible spell.Blizzard has said this is okay but has not made any commitment to put this functionality into the default UI.  Links Color-Coding Enemy Nameplates is Returning in Midnight - Wowhead News Midnight Epic Edition Contest is over Congratulations to Pandachow, NickBeresford, and Random.ffxiv

The first results from Montana's new standardized test show fewer than half of elementary-school students statewide are meeting math, reading and writing standards. The first year of testing had a rocky rollout.

Send us a textIn this episode, Dr. Elizabeth Anson and Dr. Luke Viehl from the CHNC Transport Focus Group discuss establishing consensus definitions for emergent neonatal transports across North American NICUs. Using a modified Delphi process, they surveyed 48 CHNC sites on diagnoses, clinical signs, and specialized equipment, achieving over 80% consensus in all categories. Standardized criteria aim to improve timely stabilization, support resource allocation, and facilitate advocacy with hospital administrators and insurers. Practical implications include guiding training, optimizing transport team composition, and integrating with initiatives such as therapeutic hypothermia for HIE. This work lays the foundation for research, system-level improvements, and safer, more equitable neonatal transport practices.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

This conversation with Dee Scarano delves into the concept of psychological safety, emphasizing the importance of honesty and vulnerability in communication. Dee shares how fear of judgment can hinder open expression and explore practical strategies for creating an environment where individuals feel safe to share their thoughts. They highlight the significance of anonymity, comfort zones, and standardized formats in fostering inclusivity and collaboration.    Honesty in communication fosters psychological safety. Psychological safety allows individuals to voice their thoughts without fear. Fear of judgment is a significant barrier to open communication. Anonymity is crucial for creating a safe space for sharing ideas. Building comfort zones is essential before encouraging risk-taking. Standardized formats help ensure equal contributions from all participants. Facilitators must create structures that promote psychological safety. Understanding human behavior is key to effective facilitation. Sharing knowledge within the facilitation community is vital. Vulnerability can lead to stronger connections and collaboration. Learn more about Dee - https://www.deescarano.com/ Dee on LinkedIn - https://www.linkedin.com/in/deescarano/ Support the podcast - www.verticalplaypen.org Music and sound effects - www.epidemicsound.com    

Links & Mentions: Consult booking link: www.dryazdancoaching.com/consult Email me: DrDYazdan@gmail.com Make more money video: www.dryazdancoaching.com/MDM Follow me for more tips: (@DrYazdan) www.instagram.com/dryazdan and (@DrYazdanCoaching) www.Instagram.com/dryazdancoaching Let's talk about freedom. Not just more money or more patients—but actual freedom in your dental practice. In today's episode, Dr. Yazdan breaks down why lack of systems is the biggest bottleneck keeping dental practice owners overwhelmed, overworked, and underpaid. This episode is for the dentist who's already doing well—but knows there's another level of growth and ease that feels totally out of reach. The answer isn't better staff. It's not more technology. It's building the right systems.

CBS EYE ON THE WORLD WITH JOHN BATCHELOR THE SHOW BEGINS IN THE DOUBTS ABOUT THE FATE OF GAZA.. 1945N GAZA RAILROAD 9-29-2025 FIRST HOUR 9-915 BILL-ROGGIO-HUSAIN-HAQQANI-9-29.mp3 HEADLINE: Afghanistan Hostage Release, Bagram Debate, and Skepticism on Gaza Peace Plan GUEST NAME: Bill Roggio and Husain Haqqani 50 WORD SUMMARY: Americancitizen Amir Amiri was released by the Taliban, though likely at the cost of a US prisoner. The concept of reclaiming Bagram is viewed as a risky, impractical negotiating ploy. Discussion covered tens of thousands of Afghans left behind. Experts expressed skepticism regarding the Gaza 21-point plan due to many moving parts and Hamas's goals.   915-930 BILL-ROGGIO-HUSAIN-HAQQANI-9-29.mp3 HEADLINE: Afghanistan Hostage Release, Bagram Debate, and Skepticism on Gaza Peace Plan GUEST NAME: Bill Roggio and Husain Haqqani 50 WORD SUMMARY: Americancitizen Amir Amiri was released by the Taliban, though likely at the cost of a US prisoner. The concept of reclaiming Bagram is viewed as a risky, impractical negotiating ploy. Discussion covered tens of thousands of Afghans left behind. Experts expressed skepticism regarding the Gaza 21-point plan due to many moving parts and Hamas's goals. 930-945 MORSE-TAN-9-29.mp3 HEADLINE: South Korea Faces "Techno-Totalitarianism" After Suspicious Data Center FireGUEST NAME: Morse Tan 50 WORD SUMMARY: A suspicious battery blaze paralyzed over 600 South Koreangovernment services, raising questions about server security and the destruction of intelligence. The timing is critical, disabling background checks on Chinese entrants. President Yoon Suk Yeol is strongly allied with the CCP, having purged military leadership. This incident, likened to the Reichstag fire, poses a grave threat to democracy and fosters "techno-totalitarianism."945-1000 MARK-CLIFFORD2-9-29.mp3 HEADLINE: Jimmy Lai's Imprisonment Highlights UK's "Stovepiped" Diplomacy with China GUEST NAME: Mark Clifford 50 WORD SUMMARY: Jimmy Lai, a jailed British citizen and prominent Hong Kong dissident, is a litmus test for freedom. The Starmer government is now showing movement, potentially working with the US for his release. The UK faces criticism for "stovepiping" diplomacy, failing to link Lai's freedom to economic issues, such as China's desired mega embassy. China asserts ownership over Lai based on his ethnicity. SECOND HOUR 10-1015 JANETYN-SAYEH-9-29.mp3 HEADLINE: Iran Faces Full UN Sanctions Snapback; Gen Z Leads Domestic OppositionGUEST NAME: Janet Sayeh 50 WORD SUMMARY: The West successfully enacted UN sanctions "snapback," reimposing sanctions lifted since 2015. The economy is already shocked, though enforcement against illicit networks depends on Washington. Iran may risk Israeli military action by continuing its nuclear program. Gen Z has categorically rejected the regime, leading major uprisings. The opposition is actively working to encourage defections within the security establishment.V 1015-1030 JANET-SAYEH-9-29.mp3 HEADLINE: Iran Faces Full UN Sanctions Snapback; Gen Z Leads Domestic OppositionGUEST NAME: Janet Sayeh 50 WORD SUMMARY: The West successfully enacted UN sanctions "snapback," reimposing sanctions lifted since 2015. The economy is already shocked, though enforcement against illicit networks depends on Washington. Iran may risk Israeli military action by continuing its nuclear program. Gen Z has categorically rejected the regime, leading major uprisings. The opposition is actively working to encourage defections within the security establishment.1030-1045 DAVID-DAOUD-9-29.mp3 HEADLINE: IDF Faces Urban Combat; Hezbollah Rearms Aided by Iran; Golan Heights Non-Negotiable GUEST NAME: David Daoud 50 WORD SUMMARY: IDF operations in Gaza face difficulties due to urban fighting, personnel shortages, and international pressure. Hezbollah is actively rearming, supported quietly by Iranian funds and weapons smuggling efforts. The Lebanese government is failing to disarm Hezbollah. Israelmaintains the strategically vital Golan Heights are non-negotiable for the foreseeable future, despite security discussions with the Syrian government. 1045-1100 DAVID-DAOUD-9-29.mp3 HEADLINE: IDF Faces Urban Combat; Hezbollah Rearms Aided by Iran; Golan Heights Non-Negotiable GUEST NAME: David Daoud 50 WORD SUMMARY: IDF operations in Gaza face difficulties due to urban fighting, personnel shortages, and international pressure. Hezbollah is actively rearming, supported quietly by Iranian funds and weapons smuggling efforts. The Lebanese government is failing to disarm Hezbollah. Israelmaintains the strategically vital Golan Heights are non-negotiable for the foreseeable future, despite security discussions with the Syrian government. THIRD HOUR 1100-1115 BLAINE-HOLT-9-29.mp3 HEADLINE: Russian Probes, European Escalation Rhetoric, and the Threat of Drone Swarms GUEST NAME: General Blaine Holt 50 WORD SUMMARY: Russian aircraft regularly probe the Alaskan ADIZ, met by US F-16s. Standardized procedures minimize miscalculation risk. Reckless rhetoric from European allies threatens escalation by suggesting shooting down Russian jets violating NATO airspace. European defense ministers are planning a "drone wall" to counter massive Russian drone swarms, which Ukraine currently cannot defeat. 1115-1130 BLAINE-HOLT-9-29.mp3 HEADLINE: Russian Probes, European Escalation Rhetoric, and the Threat of Drone Swarms GUEST NAME: General Blaine Holt 50 WORD SUMMARY: Russian aircraft regularly probe the Alaskan ADIZ, met by US F-16s. Standardized procedures minimize miscalculation risk. Reckless rhetoric from European allies threatens escalation by suggesting shooting down Russian jets violating NATO airspace. European defense ministers are planning a "drone wall" to counter massive Russian drone swarms, which Ukraine currently cannot defeat. 1130-1145 ALEJANDRO-PENA-ESCLUSA-9-29.mp3 HEADLINE: Venezuela's Crisis and Maduro's Drug Cartel: US Intervention Anticipated GUEST NAME: Alejandro Peña Esclusa 50 WORD SUMMARY: Venezuela is enduring a humanitarian crisis under Nicolás Maduro, leader of the Cartel of the Suns. The elected opposition, Edmundo González and María Corina Machado, have publicly authorized US intervention. Maduro's desperate letter to Trumpwas rejected as full of lies. Regional allies like Lula and Petro fear US action and indirectly try to save Maduro. 1145-1200 ALEJANDRO-PENA-ESCLUSA-9-29.mp3 HEADLINE: Venezuela's Crisis and Maduro's Drug Cartel: US Intervention Anticipated GUEST NAME: Alejandro Peña Esclusa 50 WORD SUMMARY: Venezuela is enduring a humanitarian crisis under Nicolás Maduro, leader of the Cartel of the Suns. The elected opposition, Edmundo González and María Corina Machado, have publicly authorized US intervention. Maduro's desperate letter to Trumpwas rejected as full of lies. Regional allies like Lula and Petro fear US action and indirectly try to save Maduro. FOURTH HOUR 12-1215 AHMAD-SHARAWI-9-29.mp3 HEADLINE: Al-Sharaa Seeks Normalization at UN Amid Sanctions and Domestic Tensions GUEST NAME: Ahmad Sharawi 50 WORD SUMMARY: Syrian strongman Al-Sharaa visited the UNseeking international normalization and to consolidate domestic power. He met world leaders and sought removal of Caesar sanctions, though Congress must approve this. World leaders mostly ignored questions about massacres. Major powers remain in Syria, and Kurds are negotiating integration, while Israel pursues a security agreement. 1215-1230 AHMAD-SHARAWI-9-29.mp3 HEADLINE: Al-Sharaa Seeks Normalization at UN Amid Sanctions and Domestic Tensions GUEST NAME: Ahmad Sharawi 50 WORD SUMMARY: Syrian strongman Al-Sharaa visited the UNseeking international normalization and to consolidate domestic power. He met world leaders and sought removal of Caesar sanctions, though Congress must approve this. World leaders mostly ignored questions about massacres. Major powers remain in Syria, and Kurds are negotiating integration, while Israel pursues a security agreement. 1230-1245 BRIDGET-TOOMEY-9-29.mp3 HEADLINE: Houthi Attacks Escalate: Targeting Shipping and Deploying Cluster Munitions GUEST NAME: Bridget Toomey 50 WORD SUMMARY: The Houthis struck a Netherlands-flagged cargo ship in the Gulf of Aden. The international community is quiet, as the Houthis interpret the US ceasefire as full permission to target Israel. They are also deploying cluster munition warheads on ballistic missiles against Israel. Houthisystems seem to be improving, penetrating Israeli defenses. CENTCOM considers the current US hands-off policy a strategic defeat. 1245-100 AM KEVIN-FRAZIER-9-29.mp3 HEADLINE: Russian Spy Ships Target Vulnerable Undersea Communication CablesGUEST NAME: Kevin Frazier 50 WORD SUMMARY: Undersea cables are highly vulnerable to sabotage or accidental breaks. Russia uses sophisticated naval technology, including the spy ship Yantar, to map and potentially break these cables in sensitive locations. The US is less vulnerable due to redundancy. However, protection is fragmented, relying on private owners who often lack incentives to adopt sophisticated defense techniques.

HEADLINE: Russian Probes, European Escalation Rhetoric, and the Threat of Drone Swarms GUEST NAME:General Blaine Holt 50 WORD SUMMARY: Russian aircraft regularly probe the Alaskan ADIZ, met by US F-16s. Standardized procedures minimize miscalculation risk. Reckless rhetoric from European allies threatens escalation by suggesting shooting down Russian jets violating NATO airspace. European defense ministers are planning a "drone wall" to counter massive Russian drone swarms, which Ukraine currently cannot defeat. B-36 CONVAIR

HEADLINE: Russian Probes, European Escalation Rhetoric, and the Threat of Drone Swarms GUEST NAME:General Blaine Holt 50 WORD SUMMARY: Russian aircraft regularly probe the Alaskan ADIZ, met by US F-16s. Standardized procedures minimize miscalculation risk. Reckless rhetoric from European allies threatens escalation by suggesting shooting down Russian jets violating NATO airspace. European defense ministers are planning a "drone wall" to counter massive Russian drone swarms, which Ukraine currently cannot defeat. 1870 SWEDEN

Hallie and Desi Peña of Panorama Speech chat about multilingualism: how to approach multilingual evaluations and therapy strategies.In this episode of SLP Coffee Talk, Hallie chats with Desi Peña, a Spanish-bilingual speech-language pathologist, about the real-world challenges of evaluating and supporting multilingual learners. From gathering parent input and working with interpreters to looking beyond standardized scores and trying out dynamic assessment, Desi shares practical strategies you can use right away. You'll walk away with tips to feel more confident in your evaluations, ideas for advocating with administrators, and the reminder that every child deserves to be seen for their strengths—not just a number.Bullet Points to Discuss: Multilingual evaluations and the essential information to collect.Considerations when using standardized tests with multilingual learners.Dynamic assessment and how it can guide clinical decision-making.The role of interpreters during evaluations and therapy.Strategies for supporting multilingual learners in therapy sessions.Collaboration with ESL teachers and classroom staff.Here's what we learned: Parent input is one of the most valuable tools in a multilingual evaluation.Standardized test scores don't always show the full picture.Dynamic assessment can reveal a student's true learning potential.Building strong relationships with interpreters makes the process smoother.Collaboration with teachers leads to better support for students.Every multilingual learner deserves to be seen for their strengths, not just a score.Learn more about Desi Peña: Website: www.panoramaspeech.com Instagram: @d.bilingualslp: https://www.instagram.com/d.bilingualslp @panoramaspeech: https://www.instagram.com/panoramaspeech @boldslpcollective: https://www.instagram.com/theboldslpcollective The Bold SLP Podcast: https://theboldslp.wixsite.com/theboldslpcollective Teachers Pay Teachers: https://www.teacherspayteachers.com/store/d-bilingual-slp Free Resource: https://panoramaspeech.myflodesk.com/startherefreebie Learn more about Hallie Sherman and SLP Elevate:  

Are the kids retaining the teaching? Are you just playing with kids anxiety?Standardized testing isn't a great measurement tool in my opinion.Standardized testing has been a significant part of the American education framework, but it does not meet the diverse needs of our children. From its rigid approach to the stress it generates, the inequities it reinforces, and its preference for memorization, standardized testing often falls short.As we move forward, it is vital to advocate for a more tailored and equitable educational journey. This approach should celebrate creativity, critical thinking, and each student's strengths. By challenging the reliance on standardized testing, we can foster a brighter future for our children—one that encourages a love of learning and prepares them for success in an ever-changing world.Follow us on Chan & Pods channelSubscribe to the show on YT and on your podcast apphttps://www.bonfire.com/store/the-chanbepoddin-spot/TikTok: @chanbepoddinInstagram @TheczywmbpodcastX @theczywmbpod#parentinginabetterway #cozywomb #thekids https://www.youtube.com/@chanpods Support this podcast at — https://redcircle.com/cozy-womb/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Is it time to say goodbye to your DSLR? Are mirrorless cameras really the future of dental photography? If your DSLR is still working perfectly, should you upgrade now or wait for the right time? Jaz is joined by Dr. Ashish Soneji in this game-changing episode to discuss the death of the DSLR and why the shift to mirrorless cameras is inevitable. They break down whether you should proactively switch or strategically hold off, plus what this means for your existing lenses. You'll also learn the rules of mix and match—can you use your current DSLR lens on a mirrorless body? And most importantly, which mirrorless lenses are worth buying and which ones to avoid (hint: if they don't have markings, you might be in trouble!). If you care about consistent, high-quality dental photography, this episode is a must-listen! https://youtu.be/Y29Mnz26ZIU Watch PDP239 on Youtube Protrusive Dental Pearl: Jaz introduces the 21-Day Photography Challenge for beginners, featuring 21 short videos to help dentists take clear, well-framed photos. In just three weeks, participants will master essential shots, including tricky occlusal views, at their own pace. Key Takeaways: Investing in quality equipment pays off in the long run. Mirrorless cameras offer significant advantages over DSLRs. Lighting is crucial for capturing quality images. Standardized images require barrel markings on lenses. Second-hand DSLRs can be a cost-effective option for beginners. The evolution of camera technology impacts photography practices. Choosing the right lens is essential for dental photography. Flash consistency is vital for accurate representation in images. Upgrading to mirrorless is a smart move for future-proofing photography. Upgrading your camera setup should align with your clinical progression. Mirrorless cameras are lighter and offer better image quality. Consider the size and transportability of your camera kit. Timing for upgrades can be linked to job changes or equipment failures. Image quality is influenced by megapixels, especially for presentations and printing. Using the right tools, like smaller mirrors and retractors, can improve photography outcomes. Testing second-hand cameras before purchase is crucial to avoid issues. Mobile photography is improving, but may not match the quality of dedicated cameras. Investing in good photographic equipment is essential for quality results. Highlights of this episode: 00:00 Teaser 00:47 Intro 01:41 Protrusive Dental Pearl 03:30 Ashish's Journey into Photography 09:06 The Shift from DSLR to Mirrorless Cameras 13:33 Choosing the Right Camera Setup 15:32 Upgrading to Mirrorless Cameras 19:22 Camera Recommendations for Beginners 27:23 Investing in Reliable Flash Equipment 32:20 Investing in Reliable Flash Equipment 33:48 When to Upgrade Your Camera Setup 38:08 Getting HQ Images: Mirrorless vs DSLR 42:03 Avoiding Newer Lenses 43:23 Posterior Quadrant Photography 47:50 Tips for Buying Second-Hand Cameras 49:54 Mobile Dental Photography: Are We There Yet? 53:20 Getting Your First Mirrorless Camera 55:40 Course Information 57:53 Outro

Paying for education is a major expense for many families, so I'm breaking down why 529 plans remain the preferred way to save for college, thanks to their tax advantages and flexible growth. I unpack updates, such as increased limits for K-12 tuition withdrawals, expanded uses for trade and vocational schools, and the new ability to roll funds into ABLE accounts for individuals with disabilities.  Plus, learn about the new Trump accounts, the option to roll over leftover 529 funds into your child's Roth IRA, and strategies to make the most of your education savings. Whether you're a parent, grandparent, or simply curious about planning for future expenses, this episode is packed with actionable insights to help you build a successful financial future for your family. You will want to hear this episode if you are interested in... [00:00] The One Big Beautiful Bill Act and its impact. [03:00] The two types of 529 plans - prepaid tuition and savings plans. [04:06] Paying for K through 12 tuition and out of the 529 plan up to $20,000 per year. [04:31] Wider Usage for Post-Secondary Expenses. [06:20] 529 plan rollovers to ABLE accounts. [08:52] Comparison between TRUMP accounts and 529 plans. [09:33] 529 to Roth IRA conversions. Maximizing the Power of 529 Plans Education expenses, whether for college or trade school, are among the largest financial commitments families face. Recent changes under the “One Big Beautiful Bill Act” have brought new flexibility and opportunities to the popular 529 savings plans, making it easier for parents, grandparents, and guardians to invest in the futures of their loved ones.  529 plans are tax-advantaged investment accounts designed to help families save for future education costs. Investment growth within the account is tax-deferred, and withdrawals are tax-free when used for qualified education expenses. This compounding, tax-sheltered growth can make a huge difference over 15 to 18 years, leading up to a child's college enrollment. There are two main types of 529 plans: Prepaid Tuition Plans: Lock in today's tuition rates at specific colleges or state institutions to avoid the impact of future tuition increases, which often rise more than 5% per year. Savings Plans: Flexibly invest contributions with the ability to use funds at a wide range of educational institutions across the country. Key Legislative Updates in the One Big Beautiful Bill Act 1. Doubling K-12 Tuition Withdrawals Before the new legislation, families could withdraw up to $10,000 annually for K-12 tuition expenses. The One Big Beautiful Bill Act increases this limit to $20,000 per year starting January 1, 2026.  2. Expanding Qualified Expenses for K-12 The act now permits withdrawals for a broader range of K-12-related expenses, not just tuition. As of July 5th of this year, 529 account owners can use funds for: Books and instructional materials Online educational content Professional tutoring Standardized testing fees (e.g., SAT, ACT) Educational therapies for children with disabilities 3. Supporting Trade and Technical Education Not every rewarding career requires a four-year degree. The legislative updates now allow 529 withdrawals for accredited post-secondary programs like HVAC certifications, cosmetology, apprenticeships, or trade schools. These must be programs recognized by the Workforce Innovation and Opportunity Act, lead to a military credential, or carry federal/state government approval. This opens the door for practical, career-focused education to be funded just as efficiently as traditional college. Other Savings Options Also introduced under the act is the new “TRUMP account,” which may qualify children born between 2025 and 2028 for a $1,000 government contribution, with annual after-tax contributions up to $5,000. However, unlike a 529, a TRUMP account's assets are transferred directly to the child at age 18. Many may still prefer the flexibility and parental control of a 529, but the option to use both accounts and secure extra government funding adds another layer of planning potential. Perhaps one of the most exciting new features: If a 529 account has been open for at least 15 years, up to $35,000 can be rolled, subject to annual Roth IRA limits, into a Roth IRA in a child's name. This brilliant move allows any leftover college savings to start building long-term, tax-free retirement wealth for your child, giving them a valuable head start. For families supporting someone with a disability, the ABLE (Achieving a Better Life Experience) account remains a vital tool, now bolstered by the ability to make permanent rollovers from 529 accounts. Eligible for those whose disability began before age 46 (up from age 26 next year), ABLE accounts protect benefit eligibility while allowing more robust financial support for care, therapy, and independence. Planning ahead isn't just about numbers; it's about opening doors for the next generation. Resources Mentioned Retirement Readiness Review Subscribe to the Retire with Ryan YouTube Channel Download my entire book for FREE  Workforce Innovation and Opportunity Act Connect With Morrissey Wealth Management  www.MorrisseyWealthManagement.com/contact   Subscribe to Retire With Ryan

Simon Rowley and Julian Ball join Josh Howell, LEI President, and Mark Reich, LEI Chief Engineer Strategy, and continue this month's discussion about the role of continuous improvement (CI) groups in lean management. Simon is Senior Manager at the Toyota Lean Management Centre (TLMC) in the UK, and Julian is Section Manager. TLMC was started by Toyota Motor Manufacturing UK in 2009 to support companies in the UK interested in implementing the Toyota Production System (TPS).  The two TLMC executives describe the startup of the center and how it initially enabled Toyota UK to employ and improve staff during a financial downturn. “They saw this as an opportunity for development of their own people, going out to clients and helping them and coaching them in TPS and the Toyota Way, develop them to then go rotate back into the business and make our business stronger,” says Julian. The best way to get better at TPS, adds Simon, is to practice, and TLMC offers team members opportunities to practice with diverse industries, people, problems, and environments.  On the podcast Simon and Julian also talk about:  Training programs they bring to clients in the UK, including Rolls Royce, and their work in industries beyond manufacturing, such as healthcare, pharmaceuticals, and high tech. “The thinking way can be implemented into all of these sectors,” says Julian.  The approach of TLMC team members with clients compared to staff at Toyota's internal CI group, the Operations Management Development Division (OMDD): “When we're here at Toyota and having a discussion about TPS, it's OK to assume that everyone has some level of knowledge and you can start using terms and think of activities you're going to do and everybody is kind of on the same page,” notes Simon. “If you go to an external enterprise, first of all you have to change the way you communicate to people.”  Advice for companies new to TPS and wanting to get started with improvements: get at least some advice from a lean expert, don't get too ambitious when starting with lean, begin small in an area and with people who have expressed an interest in lean improvements, make sure of who needs to be on board to make it work, and don't worry about getting it wrong.  People development and TPS: “Unless you're developing your people in your organization, you'll never maximize the potential of TPS, you'll get just little bits of improvement,” says Simon.  The importance of standardized work: “Standardized work allows us to build high-quality vehicles safely every single cycle,” say Julian. “The other part of that is it's the members' safety net. We'll train you how to do something and, of course, if you do it this way every single time you will stay safe and you will build that quality vehicle. We're avoiding any of these conflicts of who did it wrong and why didn't you do it like this. We just follow the standardized work... If I work this way, I can't do anything wrong.”  Want to take these ideas further?   Go beyond the page and see lean leadership in action. The Lean Leadership Learning Tour (Nov. 10–13, 2025) takes you inside Toyota, GE Appliances, and Summit Polymers to witness real-world problem-solving, leadership development, and transformation at scale. Bring a colleague, align your vision, and return ready to accelerate change.   Learn more » 

Boards have become a unique discipline and culture within climbing, so we created a recurring podcast focused on the latest things happening in board climbing and what it means for our sport from industry veterans and board lovers: Michael Rosato (Director of Marketing at Tension) and Joshua Horsley.'Classics' mentioned:"Effervescence" - 7A/V6 @ 45°"Clinical" - 7B/V8 @ 45°"Ignite" - 7B+/V8 @ 45°"Free Education" - 7C/V9 @ 45°Join Patreon: HERE Follow us on Instagram: HERE Visit our podcast page: HERE

Katie Wilson is the founder of Serious Moonlight Consulting, a sales and marketing leader helping tech and retail companies achieve sustainable growth. After leaving Big Tech—following 15 years at Google as Head of Sales—she has helped a variety of startups, companies, and individuals untangle and demystify their sales and marketing processes.She has been a featured speaker for @Google Talks, Wonder Women Tech, the Business Narrative Podcast, and Innovation Women. Her writing and expertise have been featured by THE BOARD and Fortune. She serves on the advisory boards of Wonder Women Tech and UCSB's Women in Leadership. Katie is known for her unique blend of creative and analytical thinking, and she loves to teach people that sales is not a dirty word.In today's episode of Smashing the Plateau, you will learn how to clarify your consulting niche, leverage your experience, and make your business development both manageable and effective.Katie and I discuss:What prompted Katie to leave corporate and start her own consulting business [01:58]The surprises and challenges of managing time and business logistics [03:00]Why focusing on a single channel is critical at the start [03:55]How Katie leveraged her experience at Google for consulting success [06:18]The importance of narrowing your niche and developing clear offerings [08:00]Standardized vs. bespoke client work [10:00]How to educate clients on what they really need [11:00]Portraying your expertise and building trust in the sales process [13:00]Katie's unique blend of creative and analytical skills [14:00]Essential elements for long-term client success [16:00]How Katie uses content and community for visibility and growth [19:00]The value and structure of consulting communities [22:00]One actionable step for corporate refugees considering entrepreneurship [24:00]Learn more about Katie at:https://www.linkedin.com/in/katiemotzwilsonhttps://www.seriousmoonlightconsulting.cohttps://www.instagram.com/seriousmoonlightconsultingThank you to our sponsor:The Smashing the Plateau CommunityDon't miss out! Get exclusive access to focused, expert-driven strategy tips—subscribe now and start taking confident action on your path to business growth!

Standardized testing: helpful measure of learning or the biggest headache in education? We're spilling the truth (and the laughs) teachers really know!   Mark your Calendars! Catch the Bored Teachers Comedy Tour coming to a city near you THIS FALL! Tickets going fast: https://bit.ly/TODBTCT    We're coming to Australia, New Zealand and Canada! We'll be heading your way this fall, and tickets are already selling fast! Grab yours NOW: https://bit.ly/TODBTCT    Book your hosts for a speaking event at your school: https://teacherspeakers.com/    Check out our MERCH! https://shop.boredteachers.com    Subscribe to our newsletter: https://www.beacons.ai/teachersoffdutypod   Send us a voice message: https://bit.ly/3UPAT5a    Listen to the podcast anywhere you stream your favorite shows:  Spotify: https://open.spotify.com/show/3hHNybdOJb7BOwe0eNE7z6?si=840ced6459274f98  Apple: https://podcasts.apple.com/us/podcast/teachers-off-duty/id1602160612  ________________________________    Teachers get your perks!! This episode is brought to you by:    Quizizz | Go to https://wayground.com/?lng=en and create a FREE account today! _________________________________ This week, Bri, KC Mack, and Anna are diving into the wild world of standardized testing — the stress, the funny fails, the endless paperwork, and why it makes both teachers and kids lose their minds. From shimmying across the Bored Teachers Comedy Tour stage to debating if kindergarteners should really be tested on life skills (like tying their shoes ), the crew gets candid about how testing impacts classrooms everywhere. We're talking testing buckets, crazy school rules, snack scandals (Oreos?!), and why teachers end up pacing thousands of steps during exam week. And of course, it wouldn't be TOD without plenty of laughter, roasting, and a few Disney detours (because yes, somehow state testing and Disney magic do connect). Whether you're a teacher, parent, or just here for the laughs, this episode will remind you why educators everywhere deserve a standing ovation. Listen now & don't forget to subscribe!  Follow your hosts:  Anna Kowal @ReadAwayWithMissK  KC Mack @kcmackfunny Briana Richardson @HonestTeacherVibes  Follow us on all platforms @TeachersOffDutyPodcast _________________________________ Teachers Off Duty - A Bored Teachers©️ Podcast

In 2015, Jeremy Tate embarked on a mission to provide alternative standardized tests rooted in tradition. It all began when Jeremy questioned how American education had come to be so utilitarian, realizing that transcendent, moral, and ethical ideas had been gutted from the classroom. He came to the conclusion that high-stakes testing was partially to blame, driving secondary school curriculum. David Coleman, CEO of the College Board, has stated publicly that “teachers will teach towards the test. There is no force on this earth strong enough to prevent that.” If teaching to the test is an inescapable reality, then shouldn't those tests engage students with the thinkers and writings that have most meaningfully shaped history and culture?  Historically, the goal of education has been understood as developing both intellect and character in students. Its purpose was to help students become better human beings. Standardized tests should reflect that same goal. They should leave students feeling inspired and enriched while equipping them to pursue their goals. That's why our tests feature beautiful and meaningful content in addition to assessing timeless academic skills. By offering a new standard for assessments, CLT aims to be a catalyst for renewal in education nationwide.

In this episode of Digital Learning Today, Jeffrey Bradbury and Stephanie Clinise explore the integration of artificial intelligence in education, specifically in high school environments. They discuss the transition challenges from middle school to high school, how AI serves as a supportive tool for teachers, and the value of personalized learning approaches. Stephanie shares her firsthand experiences using AI to boost student engagement and improve learning outcomes, while addressing the limitations of standardized teaching methods. The conversation concludes with actionable advice for educators on effectively implementing AI in both their classrooms and daily routines. Become a High-Impact Leader: This episode is just the beginning. To get the complete blueprint for designing and implementing high-impact systems in your district, get your copy of my book, "Impact Standards." Strategic Vision for Digital Learning: Learn how to create a district-wide vision that aligns digital learning with your educational goals, transforming how standards-based instruction is designed and supported. Curriculum Design and Implementation: Discover practical strategies for integrating digital learning into existing curricula, creating vertical alignment of skills, and mapping digital learning across grade levels. Effective Instructional Coaching: Master the art of coaching people rather than technology, building relationships that drive success, and measuring impact through student engagement rather than just technology usage. Purchase your copy of “Impact Standards” on Amazon today! Key Takeaways: AI serves as a support tool for teachers, not a replacement. Ninth grade represents a transformative year in students' educational journey. AI enables more personalized learning experiences for students. Educators should prioritize teaching appropriate AI usage to students. Standardized education frameworks can successfully coexist with individualized teaching approaches. AI tools reduce teacher workload and minimize decision fatigue. Teachers should share their AI success stories to promote wider adoption. Effective AI implementation enhances both student engagement and learning outcomes. Educators benefit from experimenting with AI in their personal lives before classroom implementation. Each AI tool offers distinct features and capabilities for different educational needs. Chapters: 00:00 Introduction to AI in Education 05:31 The Role of AI in High School English 10:12 Utilizing AI for Personalized Learning 13:27 Collaboration and AI Among Teachers 16:15 Rolling Out AI in Schools 19:29 Practical Applications of AI in Daily Life 26:11 Exploring AI for Personal Projects 29:37 Final Thoughts on AI in Education About our Guest: Stephanie Clinise Stephanie Clinise, M.Ed has been teaching English and Social Studies in all high school grade levels in the greater Philadelphia area for over ten years. She remains an active member of student and staff organizations in her current district, focusing on integrating educational technology and AI platforms. Stephanie works to find the best solutions for teachers, students, and staff within the technology and classroom communities while always maintaining her sense of humor and keeping the joy in education. Links of Interest Website:

Mike Rizzo is the founder of MarketingOps.com and the vibrant Mo Pros community—a 6,500+ member strong network dedicated to elevating marketing operations professionals. With a background in martech and a passion for building systems that scale, Mike champions the art of connecting strategy, technology, and people. “Marketing operations is the backbone of strategic success.” “Slow down to speed up—operational rigor helps eliminate chaos.” “Invest in your community, and it will invest back into you.” Mike Rizzo shares how marketing operations drives business success by combining strategy with execution. He explores how the Mo Pros community helps professionals connect, grow, and share. Through clear systems, thoughtful collaboration, and investment in self and others, Mike shows how ops can become a true catalyst for innovation and clarity.

In this episode you will hear:   (02:07) Question from a listener:  Number 1 Julia and Mark answer a question from Emily from Seattle about ACT/SAT scores.   (39:08) Question from a listener Number 2 Kevin and Mark discuss a question from Kevin from Arizona about getting an undergraduate degree in China   (59:06) Interview Jennifer Mandel from Milwaukee shares her experience of having a student attending a large business school is different from having a student attend a medium size business school   College Spotlight-Interview #1: Mark Stucker and Jennifer Mandel discuss students coming from under-resourced schools.   ²  I mentioned that in this interview with Jen bounces around and covers a range of topics, I asked her if she could help us to realize some of the challenges under-resourced students face, so this is a different kind of interview but one I hope you find enlightening as Jen helps us to understand some of the challenges under-resourced schools and under-resourced student face ²  Jen and I transition to our last topic and Jen talks about how her view of student loans changed ²  Jen goes on the hotseat     (01:32:00) Lisa interviews Adrienne Amador-Oddi-The VP of Queens University-Charlotte-Part 1 of 2 Part 1-Preview §  Adrienne gives an overview of Queens, aka, the elevator pitch §  Adrienne talks about the study abroad program that really impressed Lisa on her visit to Queens §  Adrienne shares the two most popular majors at Queens with some depth, and then she shares the five most popular majors at Queens §  Adrienne shares some good news for business majors at Queens §  Adrienne shares the two paths for nursing admits and great news, Queens has a direct admit option §  Adrienne talks about their very unique music therapy program       Speakpipe.com/YCBK is our method if you want to ask a question and we will be prioritizing all questions sent in via Speakpipe. Unfortunately, we will NOT answer questions on the podcast anymore that are emailed in. If you want us to answer a question on the podcast, please use speakpipe.com/YCBK. We feel hearing from our listeners in their own voices adds to the community feel of our podcast.   You can also use this for many other purposes: 1) Send us constructive criticism about how we can improve our podcast 2) Share an encouraging word about something you like about an episode or the podcast in general 3) Share a topic or an article you would like us to address 4) Share a speaker you want us to interview 5) Leave positive feedback for one of our interviewees. We will send your verbal feedback directly to them and I can almost assure you, your positive feedback will make their day.   To sign up to receive Your College-Bound Kid PLUS, our new monthly admissions newsletter, delivered directly to your email once a month, just go to yourcollegeboundkid.com, and you will see the sign-up popup. We will include many of the hot topics being discussed on college campuses.   Check out our new blog. We write timely and insightful articles on college admissions:   Follow Mark Stucker on Twitter to get breaking college admission news, and updates about the podcast before they go live. You can ask questions on Twitter that he will answer on the podcast. Mark will also share additional hot topics in the news and breaking news on this Twitter feed. Twitter message is also the preferred way to ask questions for our podcast:   https://twitter.com/YCBKpodcast   1. To access our transcripts, click: https://yourcollegeboundkid.com/category/transcripts/ 2. Find the specific episode transcripts for the one you want to search and click the link 3. Find the magnifying glass icon in blue (search feature) and click it 4. Enter whatever word you want to search. I.e. Loans 5. Every word in that episode when the words loans are used, will be highlighted in yellow with a timestamps 6. Click the word highlighted in yellow and the player will play the episode from that starting point 7. You can also download the entire podcast as a transcript   We would be honored if you will pass this podcast episode on to others who you feel will benefit from the content in YCBK.   Please subscribe to our podcast. It really helps us move up in Apple's search feature so others can find our podcast.   If you enjoy our podcast, would you please do us a favor and share our podcast both verbally and on social media? We would be most grateful!   If you want to help more people find Your College-Bound Kid, please make sure you follow our podcast. You will also get instant notifications as soon as each episode goes live.   Check out the college admissions books Mark recommends:   Check out the college websites Mark recommends:   If you want to have some input about what you like and what you recommend, we change about our podcast, please complete our Podcast survey; here is the link:     If you want a college consultation with Mark or Lisa or Lynda, just text Mark at 404-664-4340 or email Lisa at or Lynda at Lynda@schoolmatch4u.com. All we ask is that you review their services and pricing on their website before the complimentary session; here is link to their services with transparent pricing: https://schoolmatch4u.com/services/compare-packages/

  The Ruckus Report Quick take: Most principals manage buildings instead of transforming lives. Dr. Chris Jones flips the script by putting teachers at the center of every decision, creating scheduling magic that serves everyone — and proves that embracing resistance makes you stronger. Meet Your Fellow Ruckus Maker Chris Jones has been an educator in Massachusetts for 24 years. He is finishing his 16th year as a building administrator. He is a teacher centered Principal and passionate about continuous improvement and the idea that success is not a destination, but a process. Chris is the President of the Massachusetts State Administrators Association (MSAA) and was the Massachusetts School Counselors Association (MASCA) 2022 State Administrator of the Year. Chris is active on social media, vlogs about continuous improvement on a weekly basis, and hosts his own podcast called SEEing to Lead as a way to amplify teacher's voices in an effort to improve education as a whole promoting his "just cause": improving the educational experience for as many people as possible by being purposeful, acting with integrity, and building character. Breaking Down the Old Rules